-DOCSTART- O

For	O
the	O
marc	O
assays	O
,	O
marc	O
was	O
ground	O
to	O
a	O
fine	O
powder	O
using	O
a	O
Retsch	Brandname
MM	Brandname
200	Brandname
Mixer	Brandname
Mill	Brandname
-LRB-	O
Retsch	Company
GmbH	Company
,	O
Haan	O
,	O
Germany	O
-RRB-	O
and	O
was	O
substituted	O
at	O
the	O
same	O
mass	O
percentage	O
-LRB-	O
35	O
%	O
total	O
diet	O
DW	O
-RRB-	O
for	O
the	O
cellulose	O
in	O
the	O
diet	O
.	O

Inhibition	O
of	O
cell	O
proliferation	O
by	O
TQ	O
was	O
evaluated	O
6	O
h	O
post-treatment	O
using	O
a	O
colorimetric	O
WST-1	O
-LRB-	O
4	O
-	O
-LSB-	O
3	O
-	O
-LRB-	O
4-iodophenyl	O
-RRB-	O
-2	O
-	O
-LRB-	O
4-nitrophenyl	O
-RRB-	O
-2	O
H-5-tetrazolio	O
-RSB-	O
-1,3-benzenedisulfonate	O
-RRB-	O
cell	O
proliferation	O
assay	O
-LRB-	O
Roche	Company
Diagnostics	Company
GmbH	Company
,	O
Mannheim	O
,	O
Germany	O
-RRB-	O
.	O

The	O
assay	O
measures	O
the	O
ability	O
of	O
viable	O
cells	O
to	O
cleave	O
,	O
by	O
mitochondrial	O
dehydrogenases	O
,	O
the	O
WST-1	O
tetrazolium	O
salt	O
to	O
formazan	O
.	O

All	O
other	O
parameters	O
were	O
analyzed	O
by	O
Labcon	Company
GmbH	Company
-LRB-	O
Vienna	O
,	O
Austria	O
-RRB-	O
using	O
validated	O
assays	O
:	O
ASSERACHROM	Brandname
®	Brandname
b-TG	Brandname
test	Brandname
kit	Brandname
-LRB-	O
Diagnostica	Company
Stago	Company
,	O
Asniéres	O
,	O
France	O
-RRB-	O
for	O
b-TG	O
assessment	O
,	O
TAT	O
was	O
assessed	O
using	O
the	O
Enzygnost	Brandname
®	Brandname
TAT	Brandname
micro	Brandname
kit	Brandname
-LRB-	O
Siemens	Company
GmbH	Company
,	O
Munich	O
,	O
Germany	O
-RRB-	O
,	O
D-dimer	O
was	O
analyzed	O
with	O
the	O
TECHNOZYM	Brandname
®	Brandname
D-dimer	Brandname
ELISA	Brandname
-LRB-	O
Technoclone	Company
,	O
Vienna	O
,	O
Austria	O
-RRB-	O
and	O
P-selectin	O
was	O
determined	O
using	O
the	O
Human	Brandname
sP-selectin	Brandname
Platinum	Brandname
ELISA	Brandname
-LRB-	O
eBioscience	Company
,	O
CA	O
-RRB-	O
.	O

After	O
incubation	O
,	O
bacteria	O
were	O
removed	O
by	O
washing	O
twice	O
and	O
finally	O
resuspending	O
cells	O
in	O
600	O
ml	O
of	O
respiratory	O
media	O
-LRB-	O
RPMI	O
1640	O
without	O
HEPES	O
or	O
NaCO	O
3	O
,	O
pyruvate	O
-LRB-	O
2	O
mM	O
-RRB-	O
,	O
L-glutamine	O
-LRB-	O
2	O
mM	O
-RRB-	O
,	O
pH	O
7.5	O
-RRB-	O
,	O
containing	O
10	O
%	O
cefotaxime	O
-LRB-	O
100	O
mg/ml	O
-RRB-	O
-LRB-	O
ACS	Company
Dobfar	Company
Generics	Company
S.A.	Company
,	O
Luxembourg	O
,	O
Belgium	O
-RRB-	O
.	O

Cells	O
were	O
incubated	O
in	O
a	O
CO	O
2	O
free	O
incubator	O
at	O
37	O
8C	O
for	O
1	O
h	O
to	O
allow	O
temperature	O
and	O
pH	O
equilibration	O
,	O
where	O
after	O
the	O
microplate	O
with	O
cells	O
was	O
loaded	O
into	O
the	O
XF24	O
and	O
the	O
oxygen	O
consumption	O
rate	O
of	O
each	O
well	O
was	O
measured	O
over	O
a	O
period	O
of	O
100	O
min	O
.	O

Primers	O
were	O
custom	O
designed	O
and	O
synthesized	O
,	O
taking	O
basic	O
secondary	O
structure	O
into	O
account	O
during	O
the	O
design	O
process	O
-LRB-	O
PrimerDesign	Company
Ltd.	Company
,	O
UK	O
-RRB-	O
.	O

All	O
primers	O
were	O
validated	O
against	O
a	O
standard	O
complementary	O
DNA	O
-LRB-	O
cDNA	O
-RRB-	O
biobank	O
-LRB-	O
PrimerDesign	O
-RRB-	O
to	O
ensure	O
adequate	O
amplification	O
and	O
single	O
melt-curve	O
products	O
.	O

Albumin	O
was	O
measured	O
in	O
urine	O
using	O
a	O
commercially	O
available	O
immunoturbidimetric	O
assay	O
containing	O
antibody	O
specific	O
for	O
human	O
albumin	O
-LRB-	O
Randox	Company
Laboratories	Company
Ltd	Company
,	O
Crumlin	O
,	O
UK	O
-RRB-	O
.	O

Creatinine	O
was	O
measured	O
using	O
a	O
modified	O
Jaffe	O
method	O
as	O
previously	O
described	O
-LRB-	O
Roche	Company
Diagnostics	Company
,	O
Indianapolis	O
,	O
IN	O
-RRB-	O
-LRB-	O
22	O
-RRB-	O
.	O

The	O
simulator	O
used	O
was	O
the	O
commercially	O
available	O
Guildford	Brandname
MATTU	Brandname
TEP	Brandname
task	Brandname
trainer	Brandname
-LRB-	O
Limbs	Company
&	Company
Things	Company
,	Company
Ltd.	Company
,	O
Bristol	O
,	O
UK	O
-RRB-	O
,	O
12	O
which	O
consists	O
of	O
an	O
inanimate	O
,	O
box-trainer	O
type	O
simulator	O
replicating	O
the	O
preperitoneal	O
anatomy	O
of	O
a	O
right	O
groin	O
.	O

In	O
2007	O
,	O
the	O
Proximal	Device
Femoral	Device
Locking	Device
Compression	Device
Plate	Device
-LRB-	O
PFLCP	Brandname
4.5	Brandname
/	Brandname
5.0	Brandname
;	O
Synthes	Company
GmbH	Company
,	O
Zuchwil	O
,	O
Switzerland	O
-RRB-	O
was	O
introduced	O
as	O
a	O
precontoured	O
stainless-steel	Device
plate	Device
,	O
available	O
for	O
left	O
and	O
right	O
femurs	O
,	O
with	O
a	O
fix	O
angled	O
locking	O
interface	O
for	O
the	O
3	O
proximal	Device
screws	Device
-LRB-	O
958	O
,	O
1208	O
and	O
1358	O
-RRB-	O
and	O
combi-holes	O
in	O
the	O
distal	O
part	O
.	O

GSA	O
in	O
different	O
dosages	O
-LRB-	O
37.5	O
nmol	O
;	O
75	O
nmol	O
or	O
150	O
nmol/0	O
.5	O
AL	O
-RRB-	O
or	O
phosphate	O
buffered	O
saline	O
-LRB-	O
PBS	O
-RRB-	O
was	O
injected	O
i.h.	O
with	O
a	O
Microsyringe	Brandname
injection	Brandname
needle	Brandname
-LRB-	O
Innovative	Company
Labor	Company
Systems	Company
GmbH	Company
,	O
Stqtzerbach	O
,	O
Germany	O
-RRB-	O
.	O

The	O
first	O
day	O
mice	O
were	O
i.h.	O
injected	O
unilaterally	O
-LRB-	O
left	O
-RRB-	O
and	O
the	O
next	O
day	O
in	O
the	O
contralateral	O
-LRB-	O
right	O
-RRB-	O
hippocampus	O
.	O

Subsequently	O
,	O
the	O
plant	O
material	O
was	O
homogenized	O
to	O
powder	O
using	O
cutting	Device
mill	Device
Pulverisette	Brandname
19	Brandname
-LRB-	O
Fritsch	Company
,	O
GmbH	O
,	O
Idar-Oberstein	O
,	O
Germany	O
-RRB-	O
and	O
stored	O
in	O
plastic	O
bags	O
prior	O
to	O
the	O
analyses	O
.	O

Serological	O
typing	O
of	O
HLA-B	O
was	O
performed	O
using	O
the	O
standard	O
microlymphocytotoxicity	O
method	O
-LRB-	O
Innotrain	Company
Diagnostik	Company
GmbH	Company
,	O
Kronberg	O
,	O
Germany	O
-RRB-	O
.	O

HLA-DQB1	O
and	O
HLA-DRB1	O
alleles	O
were	O
detected	O
by	O
HLA-DBR1	O
and	O
HLA-DQB1	O
kits	O
-LRB-	O
Olerup	Brandname
SSP	Brandname
TM	Brandname
DQ	Brandname
kit	Brandname
,	O
Olerup	Company
SSP	Company
AB	Company
,	O
Saltsjöbaden	O
,	O
Sweden	O
-RRB-	O
using	O
sequence	O
specific	O
primer	O
-LRB-	O
SSP	O
-	O
-RRB-	O
PCR	O
method	O
.	O

Materials	O
and	O
methods	O
Materials	O
Cannabidiol	O
-LRB-	O
CBD	O
-RRB-	O
-LRB-	O
purity	O
99.4	O
%	O
-RRB-	O
was	O
purchased	O
from	O
THC	Company
Pharm	Company
GmbH	Company
-LRB-	O
Frankfurt	O
,	O
Germany	O
-RRB-	O
.	O

CBD	O
is	O
practically	O
insoluble	O
in	O
water	O
-LRB-	O
0.1	O
mg/mL	O
-RRB-	O
but	O
soluble	O
in	O
organic	Device
solvents	Device
such	O
as	O
ethanol	O
,	O
DMSO	O
,	O
and	O
dimethylformamide	O
-LRB-	O
certificate	O
of	O
analysis	O
-RRB-	O
.	O

At	O
50	O
pmol/cup	O
reactivity	O
of	O
the	O
polyclonal	O
phage	O
was	O
observed	O
selectively	O
for	O
PMP-BSA	O
but	O
not	O
for	O
BSA	O
.	O

BstO	O
I	O
-LRB-	O
Promega	Company
GmbH	Company
,	O
Mannheim	O
,	O
Germany	O
-RRB-	O
restriction	O
digest	O
of	O
20	O
colony	O
PCR	Company
products	O
indicated	O
the	O
presence	O
of	O
seven	O
different	O
clones	O
-LRB-	O
4	O
type	O
A	O
,	O
10	O
B	O
,	O
2	O
C	O
,	O
and	O
1	O
D-G	O
-RRB-	O
.	O

Insta-Gel	Brandname
XF	Brandname
and	O
Ultima-Flo	Brandname
M	Brandname
were	O
purchased	O
from	O
Packard	Company
Instrument	Company
B.V.	Company
-LRB-	O
Groningen	O
,	O
Netherlands	O
-RRB-	O
.	O

TxB2	O
,	O
12-HETE	O
and	O
12-HHT	O
were	O
purchased	O
from	O
Cayman	Company
Chemical	Company
Co.	Company
.	Company

ToF-SIMS	O
analysis	O
Ion	O
images	O
and	O
spectra	O
measurements	O
were	O
performed	O
using	O
a	O
ToFSIMS	Brandname
V	Brandname
instrument	O
-LRB-	O
ION-TOF	Company
GmbH	Company
,	O
Münster	O
,	O
Germany	O
-RRB-	O
with	O
a	O
30	O
keV	O
nano-bismuth	O
primary	O
ion	O
beam	O
source	O
-LRB-	O
Bi	O
x	O
y	O
+	O
-	O
cluster	O
ion	O
source	O
with	O
a	O
BiMn	Device
emitter	Device
of	O
the	O
latest	O
generation	O
;	O
lateral	O
resolution	O
in	O
imaging	O
mode	O
70	O
nm	O
,	O
depth	O
resolution	O
9	O
nm	O
-RRB-	O
.	O

Chemical	O
used	O
in	O
the	O
study	O
included	O
the	O
competitive	O
antagonist	O
of	O
the	O
NMDA	O
receptors	O
3	O
-	O
-LRB-	O
-LRB-	O
R	O
-RRB-	O
-2-Carboxypiperazin-4-yl	O
-RRB-	O
-	O
propyl-1phosphonic	O
acid	O
-LRB-	O
CPP	O
,	O
10	O
μM	O
;	O
Tocris	Company
Cookson	Company
Ltd	Company
,	O
UK	O
-RRB-	O
.	O

Recordings	O
and	O
data	O
processing	O
Recordings	O
started	O
approximately	O
two	O
hours	O
after	O
the	O
slices	O
were	O
placed	O
in	O
the	O
recording	O
chamber	O
and	O
continued	O
for	O
at	O
least	O
three	O
hours	O
afterwards	O
.	O

Patches	O
were	O
applied	O
for	O
2D	O
to	O
the	O
upper	O
back	O
,	O
using	O
Finn	Brandname
Chambers	Brandname
Ò	Brandname
-LRB-	O
Epitest	Company
OY	Company
,	O
Helsinki	O
,	O
Finland	O
-RRB-	O
and	O
Scanpor	Brandname
Ò	Brandname
tape	Brandname
-LRB-	O
Norges	Company
plaster	Company
A/S	Company
,	O
Oslo	O
,	O
Norway	O
-RRB-	O
.	O

Materials	O
and	O
methods	O
Materials	O
Three	O
different	O
formulations	O
for	O
inhalation	O
of	O
colistimethate	O
sodium	O
were	O
tested	O
:	O
ColiFin	O
1	O
1MIU/3	O
ml	O
-LRB-	O
Batch	O
1751691	O
-RRB-	O
and	O
ColiFin	O
1	O
2MIU/4	O
ml	O
-LRB-	O
Batch	O
1832597	O
-RRB-	O
-LRB-	O
PARI	Company
Pharma	Company
GmbH	Company
,	O
Starnberg	O
,	O
DE	O
-RRB-	O
and	O
Promixin	O
1	O
1MIU/1	O
ml	O
-LRB-	O
Batch	O
3K08PM-IT	O
-RRB-	O
-LRB-	O
Profile	Company
Pharma	Company
Ltd	Company
,	O
Chichester	O
,	O
UK	O
-RRB-	O
.	O

1MIU	O
corresponds	O
to	O
80	O
mg	O
of	O
CSM	O
.	O

Physiologic	O
saline	O
solution	O
-LRB-	O
sodium	O
chloride	O
0.9	O
%	O
w/v	O
-RRB-	O
was	O
obtained	O
by	O
Eurospital	Company
Spa	Company
-LRB-	O
Trieste	O
,	O
IT	O
-RRB-	O
;	O
purified	O
water	O
was	O
produced	O
by	O
reverse	O
osmosis	O
-LRB-	O
Milli-Q	Brandname
Gradient	Brandname
system	Brandname
,	O
Millipore	Company
,	O
Molsheim	O
,	O
FR	O
-RRB-	O
.	O

Materials	O
and	O
methods	O
chemicals	O
and	O
consumables	O
Dichloromethane	O
-LRB-	O
DcM	O
;	O
>	O
99	O
%	O
-RRB-	O
,	O
acetonitrile	O
-LRB-	O
Mecn	O
;	O
>	O
99	O
%	O
-RRB-	O
,	O
isooctane	O
-LRB-	O
>	O
99	O
%	O
-RRB-	O
,	O
and	O
aqueous	O
hydrochloric	O
acid	O
≥	O
98.5	O
%	O
;	O
sum	O
of	O
enantiomers	O
-RSB-	O
,	O
Dess-Martin	O
periodinane	O
-LSB-	O
1,1,1-tris	O
-LRB-	O
acetyloxy	O
-RRB-	O
-1,1-dihydro-1,2-benziodoxol-3	O
-	O
-LRB-	O
1H	O
-RRB-	O
-	O
one	O
,	O
97	O
%	O
-RSB-	O
,	O
and	O
D	O
-LRB-	O
+	O
-RRB-	O
-	O
glucose	O
-LRB-	O
glucose	O
;	O
≥	O
99.5	O
%	O
-RRB-	O
were	O
purchased	O
from	O
sigma-Aldrich	Company
-LRB-	O
steinheim	O
,	O
Germany	O
-RRB-	O
.	O

β-Glucuronidase/arylsulfatase	O
from	O
Helix	O
pomatia	O
was	O
supplied	O
by	O
Roche	Company
Diagnostics	Company
GmbH	Company
-LRB-	O
Mannheim	O
,	O
Germany	O
-RRB-	O
.	O

Modified	O
diatomaceous	O
earth	O
solid-supported	O
liquid-liquid	O
extraction	O
-LRB-	O
sslle	O
-RRB-	O
sorbent	O
material	O
-LRB-	O
Isolute	O
HM-n	O
,	O
bulk	O
material	O
-RRB-	O
was	O
obtained	O
from	O
biotage	Company
Ab	Company
-LRB-	O
Uppsala	O
,	O
sweden	O
-RRB-	O
.	O

empty	O
hard	O
gelatin	Device
capsules	Device
-LRB-	O
size	O
0	O
,	O
Ph.eur	O
.	O

quality	O
-RRB-	O
were	O
obtained	O
from	O
the	O
University	O
Hospital	O
Pharmacy	O
of	O
erlangen-nuremberg	O
.	O

After	O
critical	O
point	O
drying	O
,	O
the	O
protoplasts	O
were	O
mounted	O
over	O
the	O
stubs	O
with	O
double-sided	O
conductivity	O
tape	O
,	O
and	O
a	O
thin	O
layer	O
of	O
gold	O
metal	O
was	O
applied	O
over	O
the	O
samples	O
using	O
an	O
automated	O
sputter	Device
coater	Device
-LRB-	O
K500X	Brandname
,	O
Quorum	Company
Technologies	Company
Ltd	Company
,	O
United	O
Kingdom	O
-RRB-	O
.	O

The	O
samples	O
were	O
examined	O
under	O
the	O
condition	O
of	O
low	O
vacuum	O
with	O
a	O
secondary	O
electron	O
detector	O
at	O
15	O
kV	O
using	O
SEM	O
-LRB-	O
JSM-5600LV	Brandname
,	O
JEOL	Company
,	O
Japan	O
-RRB-	O
at	O
various	O
magnifications	O
-LRB-	O
Wang	O
et	O
al.	O
,	O
2010a	O
-RRB-	O
.	O


-DOCSTART- O

Specified	O
pathogen-free	O
female	O
BALB/c	Device
mice	O
-LRB-	O
5-6	O
weeks	O
old	O
-RRB-	O
were	O
obtained	O
from	O
Harlan	Company
Netherlands	Company
BV	O
-LRB-	O
Horst	O
,	O
The	O
Netherlands	O
-RRB-	O
.	O

Mice	O
were	O
housed	O
in	O
Macrolon	Brandname
III	O
cages	O
with	O
food	O
and	O
water	O
ad	O
libitum	O
.	O

The	O
stirring	O
device	O
is	O
a	O
15	O
position	O
submersible	O
magnetic	Device
stirrer	O
-LRB-	Brandname
Variomag	Brandname
HP	Brandname
15	O
,	O
art	O
no	O
41500	O
from	O
H+P	Company
Labortechnique	Company
Gmbh	O
,	O
Munich	O
Germany	O
-RRB-	O
controlled	O
by	O
Variomag	Brandname
Telemodul	Brandname
40	Brandname
S	O
-LRB-	Company
H+P	Company
Labortechnique	Company
GmbH	O
,	O
Munich	O
,	O
Germany	O
-RRB-	O
.	O

Reverse	O
transcriptase	O
PCR	O
analysis	O
of	O
mRNA	O
levels	O
Total	O
RNA	O
was	O
extracted	O
from	O
normoxic	O
control	O
and	O
48	O
h	O
CH	O
SH-SH5Y	O
cells	O
grown	O
in	O
6-well	O
plates	O
using	O
the	O
RNABee	O
reagent	O
-LRB-	Company
Biogenesis	Company
Ltd.	O
,	O
Poole	O
,	O
UK	O
-RRB-	O
according	O
to	O
the	O
manufacturer	O
's	O
instructions	O
.	O

After	O
removal	O
of	O
the	O
solvent	O
in	O
vacuo	O
,	O
the	O
catalyst	O
precursor	O
was	O
calcined	O
for	O
2	O
h	O
at	O
300	O
8C	O
in	O
a	O
muffle	Device
furnace	O
-LRB-	Brandname
mls	Brandname
1200	Brandname
pyro	O
;	O
MLS	Company
GmbH	O
,	O
Leutkirch	O
,	O
Germany	O
-RRB-	O
,	O
to	O
afford	O
a	O
catalyst	O
with	O
a	O
loading	O
of	O
1	O
wt	O
%	O
Pd	O
.	O

Total	O
RNA	O
was	O
extracted	O
with	O
RNeasy	Brandname
Mini	O
kit	O
-LRB-	Company
Qiagen	Company
GmbH	O
,	O
Hilden	O
,	O
Germany	O
-RRB-	O
according	O
to	O
the	O
manufacturer	O
's	O
protocol	O
.	O

cDNA	O
synthesis	O
was	O
performed	O
with	O
500	O
ng	O
RNA	O
using	O
First-Strand	Brandname
cDNA	Brandname
Synthesis	Brandname
Supermix	O
-LRB-	Company
TransGen	O
,	O
Beijing	O
,	O
China	O
-RRB-	O
.	O

The	O
amplifications	O
of	O
the	O
samples	O
were	O
carried	O
out	O
in	O
a	O
final	O
volume	O
of	O
20	O
l	O
using	O
QuantiTect	Brandname
Probe	Brandname
RT-PCR	O
kit	O
-LRB-	Company
Qiagen	Company
GmbH	O
,	O
Hilden	O
,	O
Germany	O
-RRB-	O
according	O
to	O
manufacturer	O
's	O
specifications	O
with	O
primers	O
from	O
Generi	Company
Biotech	O
-LRB-	O
Hradec	O
Králové	O
,	O
Czech	O
Republic	O
-RRB-	O
and	O
specific	O
TaqMan	O
probes	O
from	O
the	O
Universal	O
Probe	O
Library	O
-LRB-	Company
Roche	Company
Diagnostics	Company
GmbH	O
,	O
Mannheim	O
,	O
Germany	O
-RRB-	O
that	O
are	O
listed	O
in	O
Table	O
1	O
.	O

The	O
amplifications	O
were	O
run	O
on	O
the	O
LightCycler	O
-LRB-	Company
Roche	Company
Diagnostics	Company
GmbH	O
,	O
Mannheim	O
,	O
Germany	O
-RRB-	O
according	O
the	O
following	O
program	O
:	O
reverse	O
transcription	O
at	O
50	O
•	O
C	O
for	O
20	O
min	O
and	O
initial	O
activation	O
step	O
at	O
95	O
•	O
C	O
for	O
15	O
min	O
,	O
followed	O
by	O
40	O
cycles	O
at	O
95	O
•	O
C	O
for	O
0	O
s	O
and	O
60	O
•	O
C	O
for	O
60	O
s.	O
Batch	O
and	O
fed-batch	O
cultures	O
were	O
carried	O
out	O
in	O
2-l	O
round-bottomed	O
bioreactors	O
-LRB-	Company
Electrolab	Company
Ltd.	O
,	O
Cytotechnology	O
Tewkesbury	O
,	O
UK	O
-RRB-	O
with	O
a	O
starting	O
volume	O
of	O
1	O
l.	O
Exponentially	O
growing	O
cells	O
were	O
inoculated	O
in	O
suspension	O
at	O
2-3	O
9	O
10	O
5	O
cells/ml	O
.	O

Human	O
and	O
rodent	O
neurospheres	O
were	O
cultured	O
in	O
proliferation	O
medium	O
-LSB-	O
DMEM	O
and	O
Hams	O
F12	O
-LRB-	O
3:1	O
-RRB-	O
supplemented	O
with	O
B27	O
-LRB-	Company
Invitrogen	Company
GmBH	O
,	O
Karlsruhe	O
,	O
Germany	O
-RRB-	O
,	O
20	O
ng/mL	O
epidermal	O
growth	O
factor	O
-LRB-	O
EGF	O
;	O
Biosource	O
,	O
Karlsruhe	O
,	O
Germany	O
-RRB-	O
,	O
100	O
U/mL	O
penicillin	O
,	O
and	O
100	O
lg/mL	O
streptomycin	O
-RSB-	O
in	O
a	O
humidified	O
92.5	O
%	O
air/7	O
.5	O
%	O
CO	O
2	O
incubator	O
at	O
37	O
°C	O
in	O
suspension	O
culture	O
.	O

In	O
the	O
present	O
study	O
,	O
all	O
antagonists	O
were	O
ordered	O
commercially	O
-LRB-	Company
Sigma-Aldrich	Company
Chemie	Company
Gmbh	O
,	O
Germany	O
-RRB-	O
,	O
and	O
were	O
freshly	O
prepared	O
and	O
dissolved	O
in	O
0.9	O
%	O
saline	O
.	O

An	O
adhesive	O
wound	O
paste	O
-LRB-	Brandname
Solcoseryl	Brandname
Dental	Brandname
Adhesive	Brandname
Paste	O
,	O
MEDA	Company
Pharmaceuticals	Company
Switzerland	Company
GmbH	O
,	O
Wangen-Brüttisellen	O
,	O
Switzerland	O
-RRB-	O
was	O
then	O
applied	O
postoperatively	O
,	O
and	O
patients	O
were	O
instructed	O
to	O
apply	O
it	O
twice	O
daily	O
-LRB-	O
Fig.	O
1c	O
-RRB-	O
.	O

The	O
frequency	Device
multiplier	O
AFM6-110	O
,	O
the	O
dual-directional	Device
coupler	O
and	O
the	O
three	O
receivers	O
all	O
stem	O
from	O
Radiometer	Company
Physics	Company
GmbH	O
,	O
Meckenheim	O
,	O
Germany	O
.	O

For	O
the	O
generation	O
of	O
the	O
K	O
u	O
band	O
frequencies	O
two	O
ABSYN420	O
synthesizers	O
-LRB-	Company
AnaPico	O
,	O
Zurich	O
,	O
Switzerland	O
-RRB-	O
were	O
used	O
in	O
steps	O
of	O
250	O
MHz	O
.	O

The	O
applied	O
diagnostic	O
medical	O
device	O
was	O
the	O
non-invasive	O
,	O
Bubble	Device
Counter	O
BCC200	O
-LRB-	Company
GAMPT	Company
GmbH	O
,	O
Merseburg	O
,	O
Germany	O
-RRB-	O
,	O
a	O
pulsed	Device
ultrasonic	Device
Doppler	Device
system	O
with	O
a	O
transmission	O
frequency	O
of	O
2	O
MHz	O
,	O
measuring	O
microbubbles	O
in	O
the	O
range	O
of	O
10-500	O
µm	O
.	O

HEK293	O
cells	O
were	O
transfected	O
using	O
Genejuice	O
-LRB-	Brandname
Novagen	O
supplied	O
by	O
Merck	Company
Chemicals	Company
Ltd	O
,	O
Nottingham	O
,	O
UK	O
;	O
70967-6	O
-RRB-	O
as	O
recommended	O
by	O
the	O
manufacturers	O
instructions	O
.	O

All	O
coded	O
transcripts	O
were	O
entered	O
into	O
Atlas.ti	O
5.0.66	O
-LRB-	Company
Scientific	Company
Software	Company
Development	Company
GmbH	O
,	O
Berlin	O
,	O
Germany	O
-RRB-	O
to	O
facilitate	O
review	O
,	O
analysis	O
,	O
and	O
reporting	O
.	O

To	O
a	O
stirring	O
solution	O
of	O
Dy633	O
succinimidyl	O
ester	O
-LRB-	O
10	O
mg	O
,	O
0.012	O
mmol	O
-RRB-	O
-LRB-	Company
Dyomics	Company
GmbH	O
,	O
Jena	O
,	O
Germany	O
-RRB-	O
in	O
1	O
mL	O
anhydrous	O
DMF	O
-LRB-	O
stored	O
over	O
molecular	O
sieves	O
-RRB-	O
was	O
added	O
18-chloro-3,6,9,12-tetraoxaoctadecan-1-amine	O
hydrochloride	O
as	O
a	O
0.5	O
M	O
solution	O
in	O
DMF	O
-LRB-	O
34	O
µL	O
,	O
0.017	O
mmol	O
-RRB-	O
followed	O
by	O
diisopropylethylamine	O
-LRB-	O
5	O
µL	O
,	O
0.024	O
mmol	O
-RRB-	O
.	O

Heart	O
rate	O
,	O
as	O
an	O
indicator	O
for	O
autonomic	O
stress	O
responsiveness	O
,	O
was	O
measured	O
using	O
a	O
portable	O
heart	Device
rate	Device
monitoring	Device
device	O
-LRB-	Brandname
Polar	Brandname
S810	O
,	O
Polar	Company
Electro	Company
Oy	O
,	O
Kempele	O
,	O
Finland	O
-RRB-	O
,	O
with	O
aggregated	O
beat-to-beat	O
analyses	O
in	O
1-min	O
intervals	O
-LRB-	O
beats/min	O
-RRB-	O
from	O
À5	O
to	O
+5	O
min	O
relative	O
to	O
the	O
stressor	O
-LRB-	O
20	O
units	O
-RRB-	O
.	O

Starting	O
on	O
PND	O
123-126	O
,	O
the	O
MS15	O
,	O
MS360	O
and	O
AFR	O
males	O
were	O
placed	O
in	O
adjustable	O
transparent	O
plastic	O
restrainers	O
-LRB-	Company
AgnTho	Company
's	Company
AB	O
,	O
Stockholm	O
,	O
Sweden	O
-RRB-	O
with	O
a	O
size	O
appropriate	O
to	O
induce	O
immobilization	O
for	O
30	O
min	O
.	O

In	O
vivo	O
chlorophyll	O
a	O
-LRB-	O
Chl	O
a	O
-RRB-	O
fluorescence	O
of	O
whole	O
plants	O
was	O
recorded	O
using	O
an	O
imaging	Device
chlorophyll	Device
fluorometer	O
-LRB-	Brandname
Walz	Brandname
Imaging	Brandname
PAM	O
,	O
Walz	Company
GmbH	O
,	O
Effeltrich	O
,	O
Germany	O
-RRB-	O
by	O
exposing	O
plants	O
to	O
actinic	O
light	O
-LRB-	O
50	O
lmol	O
photons	O
m	O
À2	O
s	O
À1	O
-RRB-	O
and	O
after	O
10	O
min	O
a	O
saturating	O
light	O
flash	O
-LRB-	O
0.8	O
s	O
,	O
4000	O
lmol	O
photons	O
m	O
À2	O
s	O
À1	O
-RRB-	O
to	O
obtain	O
the	O
fluorescence-based	O
effective	O
quantum	O
yield	O
of	O
photosystem	O
II	O
-LRB-	O
PSII	O
-RRB-	O
in	O
the	O
light	O
-LRB-	O
U	O
II	O
-RRB-	O
-LRB-	O
Genty	O
et	O
al.	O
,	O
1989	O
-RRB-	O
.	O

Panorama	O
images	O
were	O
assembled	O
from	O
a	O
series	O
of	O
images	O
and	O
combined	O
by	O
a	O
panoramic	Device
stitching	Device
software	O
-LRB-	Brandname
PTGui	O
,	O
New	Company
House	Company
Internet	Company
Services	Company
BV	O
,	O
Rotterdam	O
,	O
Netherlands	O
-RRB-	O
.	O

For	O
fluorescent	O
imaging	O
,	O
erythrocytes	O
were	O
incubated	O
with	O
300	O
nM	O
nile	O
red	O
-LRB-	O
a	O
hydrophobic	O
probe	O
for	O
membrane	O
detection	O
-RRB-	O
at	O
room	O
temperature	O
for	O
20	O
min	O
in	O
HBSS	O
.	O

Analysis	O
and	O
data	O
presentation	O
Data	O
were	O
displayed	O
using	O
CHART	Device
RUNNER	O
,	O
version	O
3.0	O
-LRB-	Company
PQ	Company
Systems	Company
Europe	Company
Ltd	O
,	O
Formby	O
,	O
UK	O
-RRB-	O
.	O

The	O
standard	O
control	O
chart	O
method	O
was	O
used	O
to	O
interpret	O
patterns	O
of	O
variation	O
in	O
data	O
over	O
time	O
.	O


-DOCSTART- O

Adenoid	O
cell	O
separation	O
Adenoids	O
were	O
pressed	O
through	O
a	O
filter	O
in	O
order	O
to	O
eliminate	O
stromal	O
tissue	O
;	O
adenoidal	O
mononuclear	O
cells	O
-LRB-	O
AMC	O
-RRB-	O
were	O
then	O
isolated	O
by	O
FicollHypaque	O
density	O
gradient	O
centrifugation	O
and	O
re-suspended	O
in	O
complete	O
medium	O
-LSB-	O
RPMI	O
1640	O
-LRB-	O
Gibco	Brandname
,	O
Life	Company
Technologies	Company
Ltd	Company
,	O
Paisley	O
,	O
UK	O
-RRB-	O
supplemented	O
with	O
heat-inactivated	O
10	O
%	O
foetal	O
calf	O
serum	O
-LRB-	O
FCS	O
;	O
Euroclone	Company
-RRB-	O
,	O
2.5	O
mmol/l	O
of	O
l-glutamine	O
-LRB-	O
Gibco	Brandname
-RRB-	O
and	O
50	O
lg/ml	O
of	O
gentamycin	O
-LRB-	O
Gibco	Brandname
-RRB-	O
-RSB-	O
.	O

A	O
1.9-cm	O
diameter	O
planar	Device
transducer	Device
-LRB-	Brandname
model	Brandname
V308	Brandname
,	O
nominal	O
center	O
frequency	O
=	O
5	O
MHz	O
,	O
Panametrics	Company
NDT	Company
Ltd.	Company
,	O
UK	O
-RRB-	O
,	O
was	O
driven	O
by	O
a	O
short	O
duration	O
impulsive	O
signal	O
.	O

Western	O
blot	O
analysis	O
Equal	O
quantity	O
of	O
protein	O
-LRB-	O
40	O
g	O
-RRB-	O
was	O
electrophoresed	O
on	O
10	O
%	O
SDSpolyacrylamide	O
gel	O
and	O
transferred	O
onto	O
nitrocellulose	O
-LRB-	O
Sartorius	Company
AG	Company
,	O
Germany	O
-RRB-	O
Present	O
study	O
R-5	O
-	O
GTGATGGGATTTCCATTGAT-3	O
All	O
the	O
primers	O
were	O
synthesized	O
by	O
Microsynth	Company
GmbH	Company
,	O
Switzerland	O
.	O

10	O
Forskolin	O
Homo	O
sapiens	O
chromosome	O
10	O
genomic	O
contig	O
reference	O
assembly	O
features	O
in	O
this	O
part	O
of	O
subject	O
sequence	O
:	O
Phospho	O
fructokinase	O
.	O

Semen	O
volume	O
was	O
measured	O
by	O
weighing	O
the	O
collection	O
receptacle	O
with	O
and	O
without	O
semen	O
on	O
a	O
Sartorius	Brandname
balance	Brandname
-LRB-	O
Tillquist	Company
Analysis	Company
AB	Company
,	O
Stockholm	O
,	O
Sweden	O
-RRB-	O
.	O

For	O
each	O
specimen	O
,	O
450	O
mL	O
of	O
the	O
ejaculate	O
remaining	O
after	O
the	O
analyses	O
already	O
described	O
in	O
this	O
paragraph	O
was	O
removed	O
with	O
an	O
ordinary	O
airdisplacement	Device
pipette	Device
and	O
then	O
mixed	O
with	O
50	O
mL	O
of	O
benzamidine	O
-LRB-	O
0.1	O
M	O
-RRB-	O
to	O
stop	O
the	O
biochemical	O
processes	O
involved	O
in	O
liquefaction	O
.	O

SiLi	Device
ZYP	Device
yttrium	Device
oxide	Device
stabilized	Device
zirconia	Device
milling	Device
beads	Device
with	O
0.1-0.2	O
mm	O
diameter	O
were	O
obtained	O
from	O
Sigmund	Company
Lindner	Company
GmbH	Company
-LRB-	O
Warmensteinach	O
,	O
Germany	O
-RRB-	O
.	O

Water	O
was	O
used	O
in	O
MilliQ	O
grade	O
.	O

Nanosuspension	O
preparation	O
Fenofibrate	O
nanosuspension	O
preparation	O
was	O
performed	O
by	O
wet-milling	O
in	O
a	O
stirred	O
ball	Device
mill	Device
-LRB-	O
DynoMill	Brandname
RL	Brandname
,	O
Willy	O
A.	O
Qualitative	O
data	O
were	O
analyzed	O
using	O
ATLAS.ti	Brandname
version	O
7.0	O
-LRB-	O
ATLAS.ti	Company
GmbH	Company
,	O
Berlin	O
,	O
Germany	O
-RRB-	O
.	O

A	O
coding	O
scheme	O
was	O
developed	O
based	O
on	O
the	O
semistructured	O
Cognitive	O
Debriefing	O
Interview	O
Guide	O
and	O
applied	O
to	O
all	O
transcripts	O
.	O

Having	O
been	O
blocked	O
in	O
a	O
blocking	O
buffer-TBS	O
,	O
pH	O
7.5	O
,	O
containing	O
100	O
mM	O
Tris-HCl	O
,	O
0.9	O
%	O
NaCl	O
,	O
0.05	O
%	O
Tween-20	O
-LSB-	O
TBS-T	O
-RSB-	O
,	O
and	O
1	O
%	O
bovine	O
serum	O
albumin	O
,	O
sections	O
were	O
incubated	O
with	O
primary	O
rabbit	O
polyclonal	O
antibodies	O
against	O
hCG	O
-LRB-	O
DAKO	Company
A/S	Company
,	O
Glostrup	O
,	O
Denmark	O
-RRB-	O
and	O
sheep	O
polyclonal	O
antibodies	O
against	O
LH/hCGR	O
-LRB-	O
Biotrend	Company
Chemikalien	Company
GmbH	Company
,	O
Cologne	O
,	O
Germany	O
-RRB-	O
,	O
both	O
diluted	O
1:200	O
in	O
the	O
same	O
solution	O
for	O
60	O
min	O
at	O
37	O
°C	O
in	O
a	O
humidified	Device
chamber	Device
and	O
washed	O
for	O
60	O
min	O
in	O
TBS-T	O
.	O

Spirometry	O
:	O
FEV	O
1	O
was	O
measured	O
by	O
spirometer	Device
-LRB-	O
Master	Brandname
Screen	Brandname
,	O
Erich	Company
Jaeger	Company
GmbH	Company
,	O
Wuerzburg	O
,	O
Germany	O
-RRB-	O
;	O
the	O
highest	O
of	O
three	O
successive	O
measurements	O
was	O
taken	O
.	O

Maleic	O
acid	O
-LRB-	O
99	O
%	O
pure	O
,	O
lot	O
4039128	O
-RRB-	O
was	O
purchased	O
from	O
Sigma-Aldrich	Company
Chemie	Company
GmbH	Company
-LRB-	O
Steinheim	O
,	O
Germany	O
-RRB-	O
.	O

Sodium	O
oleate	O
-LRB-	O
82.7	O
%	O
pure	O
,	O
lot	O
51110	O
-RRB-	O
was	O
obtained	O
from	O
Riedel-de	Company
Haën	Company
,	O
Seelze	O
,	O
Germany	O
.	O

The	O
integral	O
data	O
were	O
grouped	O
and	O
sorted	O
,	O
and	O
then	O
the	O
spectral	O
intensity	O
was	O
normalized	O
to	O
a	O
unit	O
area	O
with	O
the	O
appropriate	O
weighting	O
coefficients	O
in	O
Microsoft	O
®	O
Excel	O
spreadsheets	O
prior	O
to	O
importing	O
into	O
the	O
SIMCA-P	Brandname
v11	O
.0	O
software	Device
package	Device
-LRB-	O
Umetrics	Company
AB	Company
,	O
Umeå	O
,	O
Sweden	O
-RRB-	O
for	O
multivariate	O
data	O
analysis	O
.	O

PCA	O
was	O
conducted	O
for	O
the	O
entire	O
dataset	O
using	O
mean-centered	O
data	O
.	O

The	O
reaction	O
was	O
carried	O
out	O
in	O
50	O
ml	O
volumes	O
containing	O
0.3	O
mg/ml	O
BSA	O
-LRB-	O
Bovine	O
Serum	O
Albumin	O
-RRB-	O
,	O
250	O
mM	O
dTNPs	O
,	O
0.5	O
mM	O
of	O
each	O
primer	O
,	O
0.02	O
U	O
Phusion	Brandname
High-Fidelity	Brandname
DNA	Brandname
Polymerase	Brandname
-LRB-	O
Finnzymes	Company
OY	Company
,	O
Espoo	O
,	O
Finland	O
-RRB-	O
and	O
5x	O
Phusion	Brandname
HF	Brandname
Buffer	Brandname
containing	O
1.5	O
mM	O
MgCl	O
2	O
.	O

Expired	O
13	O
CO	O
2	O
enrichment	O
was	O
measured	O
using	O
a	O
continuous	O
flow	O
isotope	Device
ratio	Device
mass	Device
spectrometer	Device
-LRB-	O
IRMS	O
,	O
Isoprime	Company
Ltd	Company
,	O
Cheadle	O
,	O
UK	O
-RRB-	O
and	O
expressed	O
as	O
atom	O
percent	O
excess	O
-LRB-	O
APE	O
-RRB-	O
when	O
compared	O
against	O
a	O
reference	O
standard	O
of	O
compressed	O
CO	O
2	O
.	O

a	O
Healthy	O
children	O
were	O
selected	O
to	O
represent	O
the	O
wide	O
range	O
in	O
age	O
of	O
PKU	O
children	O
recruited	O
for	O
the	O
study	O
-LRB-	O
see	O
Table	O
2	O
-RRB-	O
.	O

Previous	O
studies	O
-LRB-	O
e.g.	O
17	O
-RRB-	O
have	O
shown	O
when	O
such	O
feedback	O
is	O
used	O
,	O
there	O
are	O
no	O
significant	O
changes	O
in	O
the	O
levels	O
of	O
activity	O
maintained	O
by	O
the	O
*	O
Digitimer	Company
Ltd	Company
,	O
Hertfordshire	O
,	O
UK	O
.	O

†	O
Gould	Company
Electronics	Company
Inc.	Company
,	O
Chandler	O
,	O
AZ	O
,	O
USA	O
.	O

subjects	O
from	O
one	O
sequence	O
to	O
another	O
.	O

Immunodepletion	O
of	O
DNA	O
helicase	O
and	O
ssDNA-dependent	O
ATPase	O
activities	O
of	O
PfH45	Device
Aliquots	O
of	O
30	O
nM	O
purified	O
PfH45	O
were	O
incubated	O
separately	O
at	O
4	O
°C	O
for	O
16	O
h	O
with	O
2	O
μg	O
of	O
PfH45	O
IgG	O
,	O
preimmune	O
IgG	O
or	O
penta-His	O
antibodies	O
-LRB-	O
Qiagen	Company
,	Company
GmbH	Company
,	O
Germany	O
-RRB-	O
.	O

Immunodepletion	O
was	O
performed	O
by	O
adding	O
10	O
μl	O
of	O
protein	O
A-Sepharose	O
beads	O
-LRB-	O
Amersham	Company
-RRB-	O
equilibrated	O
in	O
100	O
mM	O
Tris-HCl	O
buffer	O
-LRB-	O
pH	O
8.0	O
-RRB-	O
.	O

The	O
applied	O
voltage	O
was	O
monitored	O
using	O
an	O
oscilloscope	Device
-LRB-	O
TDS	Brandname
210	Brandname
,	O
Tektronix	Company
,	Company
UK	Company
Ltd.	Company
,	O
Bracknell	O
,	O
UK	O
-RRB-	O
.	O

Microscopy	O
pictures	O
and	O
videos	O
were	O
generated	O
using	O
a	O
Dino-Lite	O
digital	Device
microscope	Device
-LRB-	O
AM413T5	Brandname
Dino-Lite	Brandname
Pro	Brandname
,	O
AnMo	Company
Electronics	Company
Corporation	Company
,	O
Hsinchu	O
,	O
Taiwan	O
-RRB-	O
.	O

Twin-beam	O
DE-CTA	O
was	O
performed	O
using	O
a	O
128-slice	O
singlesource	O
CT	Device
scanner	Device
-LRB-	O
CT	Brandname
Definition	Brandname
AS	Brandname
+	Brandname
;	O
Siemens	Company
Healthcare	Company
GmbH	Company
,	O
Erlangen	O
,	O
Germany	O
-RRB-	O
equipped	O
with	O
a	O
split-filter	Device
and	O
a	O
single-layer	O
integrated	Device
circuit	Device
detector	Device
-LRB-	O
Stellar	Brandname
;	O
Siemens	Company
Healthcare	Company
,	O
Forchheim	O
,	O
Germany	O
-RRB-	O
.	O

PCR	O
was	O
performed	O
with	O
specific	O
primers	O
using	O
200	O
ng	O
of	O
the	O
bisulfite-modified	O
genomic	O
DNA	O
as	O
templates	O
and	O
EpiTect	Brandname
MSP	Brandname
kit	Brandname
-LRB-	O
QIAGEN	Company
GmbH	Company
,	O
Hilden	O
,	O
Germany	O
-RRB-	O
.	O

The	O
cycling	O
conditions	O
consisted	O
of	O
an	O
initial	O
denaturation	O
step	O
at	O
95	O
°C	O
for	O
5	O
min	O
,	O
followed	O
by	O
31	O
cycles	O
at	O
94	O
°C	O
for	O
30	O
s	O
,	O
55	O
°C	O
for	O
30	O
s	O
,	O
and	O
72	O
°C	O
for	O
45	O
s	O
,	O
the	O
PCR	O
products	O
-LRB-	O
15	O
μl	O
-RRB-	O
were	O
resolved	O
on	O
a	O
3	O
%	O
agarose	O
gel	O
.	O

Gene	O
Ontology	O
Analysis	O
Gene	O
Ontology	O
-LRB-	O
GO	O
-RRB-	O
analysis	O
was	O
performed	O
using	O
GOSSIP	Brandname
27	Brandname
-	O
a	O
freely	O
available	O
software	Device
package	Device
that	O
tests	O
whether	O
a	O
molecular	O
function	O
,	O
biological	O
process	O
or	O
cellular	O
location	O
described	O
in	O
the	O
GO	O
system	O
-LRB-	O
http://www.geneontology.org/	O
-RRB-	O
,	O
the	O
so-called	O
GO	O
terms	O
,	O
is	O
significantly	O
associated	O
with	O
a	O
group	O
of	O
interesting	O
genes	O
when	O
compared	O
with	O
a	O
reference	O
group	O
-LRB-	O
MicroDiscovery	Company
GmbH	Company
,	O
Berlin	O
,	O
Germany	O
-RRB-	O
.	O

cDNA	O
Synthesis	O
,	O
Quantitative	O
Real-Time	O
PCR	O
and	O
Statistical	O
Analysis	O
cDNA	O
was	O
obtained	O
by	O
oligo	O
-LRB-	O
dT	O
-RRB-	O
16	O
-	O
primed	O
reverse	O
transcription	O
of	O
1	O
mg	O
total	O
RNA	O
using	O
SuperScript	Brandname
II	Brandname
-LRB-	O
Invitrogen	Company
-RRB-	O
.	O

Chemicals	O
Erdosteine	O
-LRB-	O
Erdostin	O
suspension	O
-RRB-	O
was	O
obtained	O
from	O
Ilsan-iltas	Company
Pharmaceuticals	Company
-LRB-	O
Istanbul	O
,	O
Turkey	O
-RRB-	O
,	O
and	O
ALA	O
was	O
obtained	O
from	O
Sigma-Aldrich	Company
Chemie	Company
GmbH	Company
-LRB-	O
Steinheim	O
,	O
Germany	O
-RRB-	O
.	O

Ketamine	O
hydrochloride	O
-LRB-	O
Ketalar	Brandname
50	O
mg/ml	O
-RRB-	O
was	O
obtained	O
from	O
Pfizer	Company
-LRB-	O
Turkey	O
-RRB-	O
,	O
and	O
xylasine	O
hydrochloride	O
-LRB-	O
Rompun	Brandname
-RRB-	O
was	O
obtained	O
from	O
Bayer	Company
-LRB-	O
Turkey	O
-RRB-	O
.	O

Entrapment	O
efficiency	O
and	O
drug	O
loading	O
capacity	O
Entrapment	O
efficiency	O
-LRB-	O
EE	O
%	O
-RRB-	O
and	O
drug	O
loading	O
capacity	O
-LRB-	O
DL	O
%	O
-RRB-	O
of	O
T-NPs	O
were	O
calculated	O
as	O
previously	O
described	O
2	O
DL	O
%	O
-LRB-	O
PTX	O
-RRB-	O
=	O
content	O
of	O
PTX	O
entrapped	O
in	O
nanoparticles	O
weight	O
of	O
nanoparticles	O
×	O
100	O
Particle	O
size	O
and	O
zeta	O
potential	O
The	O
mean	O
diameter	O
and	O
zeta-potential	O
of	O
T-NPs	O
were	O
measured	O
at	O
25	O
o	O
C	O
by	O
a	O
8	O
Zetasizer	Brandname
Nano	Brandname
ZS	Brandname
-LRB-	O
Malvern	Company
Instruments	Company
,	Company
Ltd.	Company
,	O
Malvern	O
,	O
Worcestershire	O
,	O
UK	O
-RRB-	O
.	O

All	O
the	O
tests	O
were	O
run	O
3	O
times	O
and	O
all	O
data	O
were	O
expressed	O
as	O
the	O
mean	O
±	O
SD	O
.	O


-DOCSTART- O

Serum	O
LH	O
,	O
FSH	O
,	O
and	O
testosterone	O
concentrations	O
were	O
measured	O
by	O
chemiluminescent	O
assay	O
using	O
an	O
ACS	Brandname
:	Brandname
180	Brandname
autoanalyzer	Device
-LRB-	O
Bayer	Company
Corp.	Company
.	Company

Diagnostics	Company
GmbH	Company
,	O
Leverkusen	O
,	O
Germany	O
-RRB-	O
.	O

The	O
concentrations	O
of	O
DHEA	O
,	O
dehydroepiandrosterone-sulfate	O
-LRB-	O
DHEAS	O
-RRB-	O
and	O
androstenedione	O
were	O
determined	O
by	O
RIA	O
methods	O
-LRB-	O
Immunotech	Company
,	O
Marseille	O
,	O
France	O
-RRB-	O
.	O

The	O
vendor-provided	O
software	Device
CST	Brandname
Microwave	Brandname
Studio	Brandname
-LRB-	O
CST	Brandname
MICROWAVE	Brandname
STUDIO	Brandname
,	O
CST	Company
GmbH	Company
,	O
Darmstadt	O
,	O
Germany	O
-RRB-	O
was	O
used	O
to	O
compute	O
the	O
electromagnetic	O
fields	O
.	O

The	O
signals	O
are	O
amplified	O
and	O
converted	O
into	O
NIM	O
-LRB-	O
nuclear	O
instrumentation	O
module	O
-RRB-	O
standard	O
pulses	O
using	O
an	O
ATR19-8	Brandname
amplifier/constant	Device
fraction	Device
discriminator	Device
-LRB-	O
CFD	O
-RRB-	O
-LRB-	O
Roentdek	Company
GmbH	Company
,	O
Frankfurt	O
,	O
Germany	O
-RRB-	O
.	O

A	O
TDC8HP	Brandname
time-to-digital	Device
converter	Device
-LRB-	O
TDC	Device
-RRB-	O
PCI	Device
card	Device
-LRB-	O
Roentdek	Company
GmbH	Company
,	O
Frankfurt	O
,	O
Germany	O
-RRB-	O
is	O
used	O
to	O
feed	O
the	O
signal	O
into	O
a	O
computer	O
with	O
a	O
time	O
resolution	O
of	O
25	O
ps	O
.	O

Food	O
was	O
reweighed	O
at	O
1	O
,	O
2	O
,	O
4	O
,	O
6	O
,	O
and	O
24	O
h	O
after	O
injection	O
,	O
whereas	O
body	O
weight	O
and	O
water	O
intake	O
were	O
measured	O
24	O
h	O
after	O
injection	O
using	O
a	O
Fisher	Brandname
Scientific	Brandname
FP-300	Brandname
series	O
balance	Device
-LRB-	O
Fisher	Company
Scientific	Company
Ltd.	Company
,	O
Leicester	O
,	O
UK	O
-RRB-	O
.	O

On	O
each	O
experimental	O
occasion	O
,	O
the	O
behavior	O
of	O
each	O
hamster	O
was	O
monitored	O
in	O
its	O
home	O
cage	O
for	O
5	O
sec	O
in	O
every	O
minute	O
for	O
1	O
h	O
after	O
lights	O
off	O
,	O
as	O
previously	O
described	O
-LRB-	O
13,14,29	O
-RRB-	O
.	O

Photosynthesis	O
and	O
respiration	O
versus	O
temperature	O
responses	O
Cells	O
grown	O
at	O
10	O
°C	O
in	O
logarithmic	O
growth	O
phase	O
were	O
collected	O
by	O
centrifugation	O
,	O
resuspended	O
in	O
a	O
fresh	O
BG11	O
medium	O
-LRB-	O
supplemented	O
with	O
10	O
mM	O
NaHCO	O
3	O
-RRB-	O
and	O
transferred	O
to	O
the	O
Clark	Brandname
oxygen	Brandname
electrode	Brandname
-LRB-	O
Hansatech	Company
Instruments	Company
Ltd.	Company
,	O
Norfolk	O
,	O
UK	O
-RRB-	O
chamber	O
.	O

Photosynthesis	O
under	O
the	O
saturation	O
intensity	O
-LRB-	O
about	O
700	O
lmol	O
photons	O
m	O
-2	O
s	O
-1	O
-RRB-	O
and	O
respiration	O
versus	O
temperature	O
responses	O
were	O
measured	O
at	O
5	O
,	O
10	O
,	O
15	O
,	O
20	O
,	O
25	O
,	O
30	O
and	O
35	O
°C	O
,	O
respectively	O
.	O

Methods	O
:	O
Animal	O
Studies	O
Animal	O
Husbandry	O
.	O

C57Bl/6J	Brandname
female	O
mice	Device
-LRB-	O
Envigo	Company
Ltd	Company
,	O
United	O
Kingdom	O
-RRB-	O
were	O
housed	O
on	O
a	O
12	O
hour	O
lightdark	O
cycle	O
at	O
21-23	O
°C	O
with	O
free	O
access	O
to	O
food	O
-LRB-	O
Beekay	O
Rat	O
and	O
Mouse	O
Diet	O
,	O
Bantin	O
&	O
Kingman	O
,	O
Hull	O
,	O
UK	O
-RRB-	O
and	O
water	O
.	O

Samples	O
were	O
transferred	O
into	O
two	O
low	O
mass	O
aluminum	Device
planchettes	Device
and	O
high	O
pressure	O
frozen	O
-LRB-	O
Engineering	Company
Office	Company
M.	Company
Wohlwend	Company
GmbH	Company
,	O
Sennwald	O
,	O
Switzerland	O
-RRB-	O
to	O
maintain	O
the	O
native	O
structure	O
of	O
the	O
gel	O
.	O

P188	O
Methods	O
We	O
assessed	O
changes	O
in	O
fl	O
uid	O
balance	O
and	O
performed	O
daily	O
BIA	O
-LRB-	O
using	O
a	O
Maltron	Brandname
BioScan	Brandname
920-II	Brandname
;	O
Maltron	Company
International	Company
Ltd	Company
,	O
UK	O
-RRB-	O
over	O
3	O
days	O
in	O
consecutive	O
ICU	O
admissions	O
with	O
LOS	O
>	O
72	O
hours	O
.	O

Data	O
analysis	O
Data	O
were	O
analyzed	O
using	O
Stats	Brandname
Direct	Brandname
-LRB-	O
Stats	Company
Direct	Company
Ltd.	Company
,	O
Cheshire	O
,	O
UK	O
-RRB-	O
.	O

A	O
Chi	O
square	O
analysis	O
with	O
untransformed	O
data	O
was	O
used	O
for	O
sample	O
comparison	O
and	O
differences	O
were	O
considered	O
significant	O
at	O
P	O
<	O
0.01	O
.	O

Reagents	O
Dulbecco	O
's	O
modified	O
Eagle	O
medium	O
-LRB-	O
DMEM	O
-RRB-	O
,	O
penicillin	O
,	O
streptomycin	O
,	O
L-glutamine	O
,	O
Hank	O
's	O
calcium-and	O
magnesium-free	O
balanced	O
salt	O
solution	O
-LRB-	O
HBSS	O
-RRB-	O
,	O
and	O
fetal	O
calf	O
serum	O
-LRB-	O
FCS	O
-RRB-	O
were	O
purchased	O
from	O
GIBCO	Company
Life	Company
Technologies	Company
,	Company
Ltd.	Company
,	O
UK	O
.	O

Halothane	O
was	O
supplied	O
by	O
May	Company
and	Company
Baker	Company
,	Company
Ltd.	Company
,	O
Dagenham	O
,	O
UK	O
,	O
and	O
alcoholic	O
Betadine	O
-LRB-	O
povidine	O
iodine	O
-RRB-	O
was	O
supplied	O
by	O
Napp	Company
Laboratories	Company
,	Company
Ltd.	Company
,	O
Cambridge	O
,	O
UK	O
.	O

For	O
sequencing	O
,	O
the	O
3L	O
and	O
4L	O
CEACAM1	O
PCR	O
products	O
were	O
excised	O
from	O
the	O
agarose	O
gel	O
,	O
purified	O
using	O
the	O
QIAquick	Brandname
Gel	Device
Extraction	Device
kit	Device
-LRB-	O
Qiagen	Company
,	Company
VWR	Company
International	Company
AB	Company
,	O
Stockholm	O
,	O
Sweden	O
-RRB-	O
and	O
quantified	O
using	O
lambda	O
DNA	O
.	O

The	O
amplification	O
was	O
performed	O
in	O
20	O
ml	O
reactions	O
containing	O
BigDye	Brandname
mix	Brandname
-LRB-	O
Applied	Company
Biosystems	Company
,	O
Warrington	O
,	O
UK	O
-RRB-	O
,	O
5-7	O
ml	O
template	O
and	O
3.2	O
mM	O
of	O
the	O
forward	O
CEACAM1	O
primer	O
at	O
551C	O
for	O
26	O
cycles	O
.	O

DNA	O
sequencing	O
For	O
DNA	O
sense	O
and	O
antisense	O
sequencing	O
,	O
PCR	O
products	O
were	O
purified	O
from	O
agarose	O
gels	O
using	O
Quiaex	Brandname
II	Brandname
gel	Device
extraction	Device
kit	Device
-LRB-	O
Quiagen	Company
GmbH	Company
,	O
Hilden	O
,	O
Germany	O
-RRB-	O
.	O

Forward	O
and	O
reverse	O
sequencing	O
reactions	O
were	O
performed	O
with	O
the	O
BigDye	Brandname
TM	Brandname
terminator	Device
cycle	Device
sequencing	Device
ready	Device
reaction	Device
kit	Device
-LRB-	O
Applied	Company
Biosystems	Company
,	O
Warrington	O
,	O
UK	O
-RRB-	O
on	O
an	O
ABI	Brandname
Prism	Brandname
TM	Brandname
377	Brandname
DNA	Device
sequencer	Device
-LRB-	O
Applied	Company
Biosystems	Company
,	O
Warrington	O
,	O
UK	O
-RRB-	O
in	O
all	O
subjects	O
with	O
abnormal	O
DGGE	O
mobility	O
patterns	O
.	O

Thereafter	O
,	O
a	O
slow	O
infusion	O
of	O
1.25	O
μl/ml	O
fentanyl	O
-LRB-	O
Fentanyl	Brandname
,	O
Pharmalink	Company
AB	Company
,	O
Stockholm	O
,	O
Sweden	O
-RRB-	O
in	O
buffered	O
glucose	O
-LRB-	O
25	O
mg/ml	O
-RRB-	O
was	O
started	O
at	O
a	O
rate	O
of	O
1.5	O
ml/min	O
and	O
adjusted	O
as	O
needed	O
.	O

The	O
prepared	O
specimens	O
were	O
mounted	O
on	O
aluminum	O
stubs	O
,	O
gold-sputtered	O
at	O
10	O
mA	O
for	O
1	O
min	O
-LRB-	O
Unit	Brandname
E500	Brandname
,	O
Polaron	Company
Equipment	Company
Ltd.	Company
,	O
Watford	O
,	O
UK	O
-RRB-	O
and	O
analyzed	O
under	O
SEM	O
-LRB-	O
1430	Brandname
VP	Brandname
,	O
LEO	Company
Electron	Company
Microscopy	Company
Ltd.	Company
,	O
Cambridge	O
,	O
UK	O
-RRB-	O
.	O

The	O
specimens	O
were	O
cut	O
in	O
half	O
using	O
a	O
diamond	Device
disk	Device
adapted	O
to	O
a	O
precision	O
cutting	Device
machine	Device
-LRB-	O
Isomet	Brandname
4000	Brandname
,	O
Buehler	Company
GmbH	Company
,	O
40599	O
Dusseldorf	O
,	O
Germany	O
-RRB-	O
.	O

The	O
two	O
fragments	O
of	O
each	O
specimen	O
were	O
randomly	O
assigned	O
to	O
the	O
LM	O
and	O
SEM	O
analysis	O
groups	O
.	O

Primers	O
were	O
designed	O
using	O
the	O
program	Device
Primer	Brandname
Premier	Brandname
-LRB-	O
Premier	Company
Biosoft	Company
,	O
USA	O
-RRB-	O
and	O
synthesized	O
using	O
a	O
DNA/RNA	Device
Synthesizer	Device
OligoMaker	Brandname
48/6	Brandname
-LRB-	O
OligoMaker	Company
ApS	Company
,	O
Denmark	O
-RRB-	O
.	O

The	O
sequencing	O
and	O
phylogenetic	O
analysis	O
of	O
these	O
genes	O
were	O
performed	O
as	O
described	O
for	O
the	O
16S	O
rDNA	O
and	O
ITS	O
.	O

The	O
purity	O
of	O
selected	O
fractions	O
was	O
verified	O
by	O
MALDI-TOF	O
-LRB-	O
Autoflex	Brandname
II	Brandname
TOF/TOF	Brandname
;	O
Bruker	Company
Daltonics	Company
GmbH	Company
,	O
Germany	O
-RRB-	O
,	O
analytical	O
reverse-phase	O
HPLC	O
,	O
and	O
size	O
exclusion	O
chromatography	O
as	O
described	O
previously	O
-LRB-	O
11	O
-RRB-	O
.	O

The	O
p53	O
wild-type	O
-LRB-	O
SKW6	O
.4	O
and	O
JVM-2	O
-RRB-	O
and	O
p53	O
mutated	O
-LRB-	O
BJAB	O
,	O
MAVER	O
-RRB-	O
B	O
leukemic	O
lines	O
were	O
purchased	O
from	O
DSMZ	Company
-LRB-	O
Deutsche	Company
Sammlung	Company
von	Company
Mikroorganismen	Company
und	Company
Zellkulturen	Company
GmbH	Company
,	O
Braunschweig	O
,	O
Germany	O
-RRB-	O
.	O

Leukemic	O
cells	O
were	O
routinely	O
cultured	O
in	O
RPMI-1640	O
medium	O
-LRB-	O
Gibco	Company
BRL	Company
,	O
Grand	O
Island	O
,	O
NY	O
-RRB-	O
.	O

For	O
secondary	O
PCR	O
amplification	O
of	O
the	O
D3S1581	O
marker	O
,	O
12.5	O
ml	O
of	O
MegaMix-double	Brandname
-LRB-	O
Microzone	Company
Ltd.	Company
,	O
Haywards	O
Heath	O
,	O
UK	O
-RRB-	O
,	O
and	O
2	O
pmol	O
of	O
each	O
forward	O
and	O
reverse	O
D3S1581	O
primer	O
were	O
used	O
in	O
a	O
25	O
ml	O
reaction	O
.	O

Measurement	O
of	O
hematological	O
traits	O
We	O
measured	O
Hb	O
concentration	O
in	O
whole	O
blood	O
using	O
a	O
HemoCue	Brandname
Hb	Brandname
201	Brandname
+	Brandname
analyzer	Device
,	O
following	O
the	O
manufacturer	O
's	O
protocol	O
-LRB-	O
HemoCue	Company
AB	Company
,	O
Ängelholm	O
,	O
Sweden	O
-RRB-	O
.	O

We	O
measured	O
Hct	O
as	O
the	O
volume	O
of	O
packed	O
RBCs	O
relative	O
to	O
total	O
blood	O
volume	O
in	O
a	O
heparinized	Device
capillary	Device
tube	Device
that	O
was	O
spun	O
at	O
13,600	O
g	O
for	O
5	O
min	O
in	O
a	O
ZIPocrit	Brandname
centrifuge	Device
-LRB-	O
LW	Company
Scientific	Company
Inc.	Company
,	O
Lawrenceville	O
,	O
GA	O
,	O
USA	O
-RRB-	O
.	O


-DOCSTART- O

After	O
a	O
subsequent	O
wash	O
in	O
PBS-T	O
,	O
membranes	Device
were	O
incubated	O
with	O
a	O
streptavidin	O
conjugated	O
Horseradish	O
Peroxidase	O
-LRB-	O
Amersham	Company
,	O
GE	Company
Healthcare	Company
UK	Company
Ltd.	Company
,	O
Little	O
Chalfont	O
,	O
UK	O
-RRB-	O
diluted	O
1:3000	O
in	O
PBS-T	O
,	O
for	O
1	O
h	O
at	O
room	O
temperature	O
.	O

Materials	O
and	O
Methods	O
The	O
Endo-Model	Brandname
rotating-hinge	Device
knee	Device
prosthesis	Device
was	O
developed	O
in	O
1979	O
by	O
Waldemar	Company
LINK	Company
GmbH	Company
-LRB-	O
Hamburg	O
,	O
Germany	O
-RRB-	O
.	O

3	O
The	O
stem	O
of	O
the	O
femoral	O
component	O
has	O
a	O
valgus	O
angle	O
of	O
6	O
°	O
.	O

Images	O
were	O
acquired	O
with	O
AxioVision	Brandname
-LRB-	O
version	O
4.8.3.0	O
;	O
Carl	Company
Zeiss	Company
MicroImaging	Company
GmbH	Company
,	O
Jena	O
,	O
Germany	O
-RRB-	O
.	O

All	O
neuronal	Device
cell	Device
bodies	Device
in	O
the	O
DRGs	O
were	O
identified	O
as	O
positive	O
for	O
bIII	O
tubulin	O
.	O

Pre-and	O
post-surgery	O
care	O
One	O
hour	O
before	O
operation	O
,	O
buprenorphine	O
-LRB-	O
0.05	O
mg/kg	O
;	O
RB	Company
Pharmaceuticals	Company
Ltd	Company
,	O
Berkshire	O
,	O
UK	O
-RRB-	O
was	O
administrated	O
subcutaneously	O
-LRB-	O
s/c	O
-RRB-	O
as	O
analgesic	O
.	O

Patient	O
dosimetry	O
is	O
performed	O
using	O
external	O
KAP-meter	Brandname
-LRB-	O
RTI	Company
Electronics	Company
AB	Company
,	O
Gothenburg	O
,	O
Sweden	O
-RRB-	O
and	O
radiochromic	Device
films	Device
-LRB-	O
Gafchromic	Brandname
XRRV2	Brandname
,	O
International	Company
Specialty	Company
Products	Company
-RRB-	O
.	O

Monoclonal	O
antibody	O
against	O
glyceraldehyde-3-phosphate	O
dehydrogenase	O
-LRB-	O
GAPDH	O
-RRB-	O
was	O
from	O
Serotec	Company
Ltd	Company
-LRB-	O
Oxford	O
,	O
UK	O
-RRB-	O
.	O

Polyclonal	O
rabbit	O
antimouse	O
immunoglobulins/HRP	O
was	O
from	O
Dakocytomation	Company
-LRB-	O
Glostrup	O
,	O
Denmark	O
-RRB-	O
.	O

The	O
40	O
kHz	O
ultrasound	Device
apparatus	Device
was	O
a	O
standard	O
ultrasonic	Device
cleaning	Device
bath	Device
375H	Device
-LRB-	O
Langford	Company
Electronics	Company
Ltd.	Company
,	O
Coventry	O
,	O
UK	O
-RRB-	O
with	O
a	O
maximal	O
electrical	O
energy	O
output	O
of	O
75	O
W	O
.	O

The	O
supernatant	O
was	O
evaporated	O
until	O
dryness	O
-LRB-	O
partial	O
vacuum	O
at	O
45	O
°C	O
,	O
SPD2010	Brandname
SpeedVac	Brandname
System	Brandname
,	O
Thermo	Company
Fisher	Company
Scientific	Company
GmbH	Company
,	O
Dreieich	O
,	O
Germany	O
-RRB-	O
.	O

Residues	O
were	O
resolved	O
in	O
200	O
μL	O
of	O
methanol	O
,	O
77.5	O
mL	O
of	O
nanopure	O
H	O
2	O
O	O
,	O
and	O
22.5	O
μL	O
of	O
HCl	O
-LRB-	O
10	O
mol/L	O
-RRB-	O
.	O

Recording	O
of	O
the	O
pupil	O
diameter	O
in	O
darkness	O
by	O
near-infrared	O
TV	O
-LRB-	O
television	O
-RRB-	O
pupillography	O
was	O
performed	O
20	O
minutes	O
after	O
dark	O
adaptation	O
using	O
the	O
compact	O
integrated	Device
pupillograph	Device
-LRB-	O
AMTech	Company
GmbH	Company
,	O
Weinheim	O
-RRB-	O
in	O
a	O
standardized	O
way	O
.	O

8	O
Devices	O
for	O
automatic	O
24-hour	O
recording	O
of	O
ambulatory	O
BP	O
-LRB-	O
Boso	Company
GmbH	Company
,	O
Jüngingen	O
,	O
Germany	O
-RRB-	O
were	O
used	O
at	O
various	O
measurement	O
intervals	O
-LRB-	O
every	O
15	O
minutes	O
during	O
the	O
day	O
and	O
every	O
30	O
minutes	O
at	O
night	O
-RRB-	O
.	O

.	O

,	O
the	O
GenoType	Brandname
MTBDRplus	Brandname
assay	Brandname
-LRB-	O
Hain	Company
Lifescience	Company
GmbH	Company
,	O
Germany	O
-RRB-	O
-LRB-	O
35	O
-RRB-	O
-LRB-	O
36	O
-RRB-	O
-LRB-	O
37	O
-RRB-	O
.	O

A	O
notable	O
drawback	O
to	O
these	O
assays	O
is	O
that	O
they	O
are	O
limited	O
to	O
detecting	O
a	O
specific	O
set	O
of	O
mutations	O
in	O
the	O
rpoB	O
,	O
katG	O
,	O
and	O
inhA	O
genes	O
-LRB-	O
e.g.	O
,	O
the	O
INNO-LiPA	Brandname
Rif.TB	Brandname
test	Brandname
detects	O
only	O
nine	O
mutations	O
in	O
rpoB	O
-RRB-	O
and	O
can	O
not	O
identify	O
novel	O
mutations	O
conferring	O
resistance	O
-LRB-	O
37	O
-RRB-	O
,	O
although	O
certain	O
assays	O
do	O
contain	O
probes	O
for	O
wildtype	O
alleles-observing	O
a	O
resistance	O
phenotype	O
and	O
a	O
wild-type	O
allele	O
would	O
suggest	O
a	O
novel	O
mutation	O
but	O
would	O
not	O
provide	O
further	O
details	O
.	O

Cultures	O
were	O
synchronized	O
in	O
G1	O
with	O
alpha	O
factor	O
mating	O
pheromone	O
for	O
3	O
h	O
-LRB-	O
CASLO	Company
ApS	Company
,	O
Denmark	O
-RRB-	O
.	O

Tus	O
expression	O
was	O
induced	O
by	O
adding	O
2	O
%	O
Galactose	O
-LRB-	O
final	O
w/v	O
-RRB-	O
for	O
the	O
final	O
2.5	O
h	O
of	O
the	O
G1-arrest	O
.	O

Porphyromonas	O
gingivalis	O
was	O
anaerobically	O
cultured	O
at	O
80	O
%	O
N	O
2	O
,	O
10	O
%	O
CO	O
2	O
,	O
and	O
10	O
%	O
H	O
2	O
at	O
37	O
°C	O
in	O
an	O
anaerobic	Device
chamber	Device
-LRB-	O
Concept	Brandname
400	Brandname
Anaerobic	Brandname
Workstation	Brandname
;	O
Ruskinn	Company
Technology	Company
Ltd.	Company
,	O
Leeds	O
,	O
UK	O
-RRB-	O
in	O
fastidious	O
anaerobe	O
broth	O
-LRB-	O
29.7	O
g/L	O
,	O
pH	O
7.2	O
-RRB-	O
.	O

The	O
onion	O
epidermal	O
cells	O
then	O
were	O
stained	O
with	O
propidium	O
iodide	O
-LRB-	O
10	O
μg/ml	O
-RRB-	O
for	O
nuclei	O
and	O
were	O
observed	O
with	O
a	O
Leica	Brandname
TCS	Brandname
SP2	Brandname
AOBS	Brandname
confocal	Device
microscope	Device
-LRB-	O
Leica	Company
Microsystems	Company
,	O
Heidelberg	Company
GmbH	Company
,	O
Germany	O
-RRB-	O
.	O

Yeast	O
one-hybrid	O
assays	O
.	O

The	O
interaction	O
of	O
OsWRKY13	O
protein	O
with	O
W	O
or	O
W-like	O
box	O
in	O
a	O
promoter	O
region	O
-LRB-	O
Supplemental	O
Table	O
3	O
-RRB-	O
was	O
examined	O
using	O
a	O
yeast	O
one-hybrid	O
assay	O
according	O
to	O
the	O
manufacturer	O
's	O
protocol	O
-LRB-	O
Clontech	Brandname
Yeast	Brandname
Protocols	Brandname
Handbook	Brandname
,	O
BD	Company
Biosciences	Company
Clontech	Company
,	O
Mountain	O
View	O
,	O
CA	O
,	O
U.S.A.	O
-RRB-	O
.	O

The	O
clinical	O
outcome	O
was	O
evaluated	O
by	O
comparing	O
the	O
preoperative	O
to	O
postoperative	O
best-corrected	O
visual	O
acuity	O
-LRB-	O
BCVA	O
-RRB-	O
,	O
noncontact	O
specular	O
microscopy	O
-LRB-	O
SP3000	Brandname
;	O
Topcon	Company
Medical	Company
Europe	Company
BV	Company
,	O
Capelle	O
a/d	O
IJssel	O
,	O
The	O
Netherlands	O
-RRB-	O
,	O
anterior	O
segment	O
optical	O
coherence	O
tomography	O
-LRB-	O
Heidelberg	Company
Engineering	Company
GmbH	Company
,	O
Heidelberg	O
,	O
Germany	O
-RRB-	O
,	O
confocal	O
microscopy	O
-LRB-	O
Confoscan	Brandname
4	Brandname
;	O
Nidek	Company
Technologies	Company
,	O
Padova	O
,	O
Italy	O
-RRB-	O
,	O
Scheimpflug	O
imaging	O
-LRB-	O
Pentacam	Brandname
HR	Brandname
;	O
Oculus	Company
,	O
Wetzlar	O
,	O
Germany	O
-RRB-	O
,	O
and	O
photo-slit-lamp	O
biomicroscopy	O
-LRB-	O
Topcon	Company
Medical	Company
Europe	Company
BV	Company
-RRB-	O
.	O

Photomicrographs	O
were	O
produced	O
using	O
a	O
Zeiss	Device
Axioskop	Device
microscope	Device
-LRB-	O
40	O
objective	O
lens	O
-RRB-	O
with	O
a	O
digital	Device
camera	Device
-LRB-	O
Carl	Company
Zeiss	Company
GmbH	Company
,	O
Jena	O
,	O
Germany	O
-RRB-	O
.	O

ATP	O
Measurements	O
.	O

Cellular	O
ATP	O
content	O
was	O
determined	O
by	O
a	O
luciferin/luciferase	O
assay	O
-LRB-	O
Bihler	O
and	O
Jeanrenaud	O
,	O
1970	O
-RRB-	O
.	O

Afterwards	O
they	O
were	O
placed	O
in	O
20	O
%	O
EDTA	O
-LRB-	O
Sigma	Company
Aldrich	Company
Chemie	Company
GmbH	Company
,	O
Steinheim	O
,	O
Germany	O
-RRB-	O
for	O
4e5	O
weeks	O
at	O
37	O
C.	O
Decalcification	O
medium	O
was	O
changed	O
every	O
2	O
or	O
3	O
days	O
.	O

All	O
straylight	O
measurements	O
were	O
done	O
using	O
the	O
C-Quant	Brandname
-LRB-	O
Oculus	Company
GmbH	Company
,	O
Wetzlar	O
,	O
Germany	O
-RRB-	O
,	O
employing	O
the	O
psychophysical	O
compensation	O
comparison	O
method	O
developed	O
by	O
van	O
den	O
Berg	O
.	O

10,11	O
The	O
procedure	O
was	O
similar	O
to	O
those	O
previously	O
reported	O
.	O

12,13	O
The	O
patient	O
was	O
instructed	O
to	O
look	O
through	O
an	O
eyepiece	O
with	O
one	O
eye	O
,	O
while	O
the	O
other	O
eye	O
was	O
patched	O
.	O

The	O
citric	O
acid	O
aerosol	O
,	O
generated	O
by	O
a	O
jet	Device
nebulizer	Device
-LRB-	O
PARI	Brandname
jet	Brandname
nebulizer	Brandname
,	O
Paul	O
Ritzau	O
,	O
Pari-Werk	Company
GmbH	Company
,	O
Germany	O
,	O
output	O
5	O
L	O
s	O
−	O
1	O
,	O
particles	O
mass	O
median	O
diameter	O
1.2	O
í	O
µí	O
1/4	O
‡	O
m	O
-RRB-	O
,	O
was	O
delivered	O
to	O
the	O
head	O
chamber	O
of	O
the	O
plethysmograph	O
for	O
3	O
min	O
.	O

BIBO3304	O
was	O
supplied	O
by	O
Boehringer-Ingelheim	Company
Pharma	Company
GmbH	Company
-LRB-	O
Rheinland	O
Palatinate	O
,	O
Germany	O
-RRB-	O
and	O
L152804	O
was	O
from	O
Banyu	Company
-LRB-	O
Banyu	Company
Pharmaceutical	Company
Co.	Company
,	Company
Ltd.	Company
,	O
Tokyo	O
,	O
Japan	O
-RRB-	O
.	O

The	O
arterial	O
blood	O
pressure	O
set	O
was	O
connected	O
,	O
and	O
the	O
transducer	Device
was	O
placed	O
at	O
the	O
level	O
of	O
the	O
heart	O
and	O
zeroed	O
.	O

The	O
LiDCOplus	Brandname
monitor	Brandname
-LRB-	O
LiDCO	Company
Ltd.	Company
,	O
Cambridge	O
,	O
United	O
Kingdom	O
-RRB-	O
26	O
was	O
connected	O
for	O
continuous	O
hemodynamic	O
monitoring	O
.	O


-DOCSTART- O

PUK27	O
nOctUria	O
WOrK	O
PrOdUctivity	O
and	O
activity	O
imPairment	O
cOmPared	O
tO	O
Other	O
cOmmOn	O
chrOnic	O
diseases	O
:	O
a	O
systematic	O
revieW	O
Miller	Brandname
PS	Brandname
1	Brandname
,	O
Andersson	O
FL	O
2	O
1	O
MILLER	Company
ECONOMICS	Company
LTD.	O
,	O
Alderley	O
Edge	O
,	O
UK	O
,	O
2	O
Ferring	Company
Pharmaceuticals	Company
A/S	Company
,	O
Copenhagen	O
,	O
Denmark	O
Objectives	O
:	O
Nocturia	O
is	O
defined	O
by	O
the	O
International	O
Continence	O
Society	O
as	O
the	O
need	O
to	O
void	O
one	O
or	O
more	O
times	O
during	O
the	O
night	O
,	O
with	O
each	O
of	O
the	O
voids	O
preceded	O
and	O
followed	O
by	O
sleep	O
.	O

Nutritional	O
protocol	O
All	O
infants	O
were	O
fed	O
with	O
their	O
own	O
mothers	O
'	O
milk	O
or	O
donated	O
human	O
milk	O
,	O
fortified	O
with	O
5	O
%	O
FM	O
85	O
-LRB-	O
Nestlé	Company
,	O
Munich	O
,	O
Germany	O
-RRB-	O
,	O
or	O
preterm	O
formula	O
-LRB-	O
Humana	Brandname
0	Brandname
,	O
Humana	Company
GmbH	Company
,	O
Herford	O
,	O
Germany	O
-RRB-	O
.	O

Parenteral	O
nutrition	O
was	O
started	O
in	O
infants	O
b	O
1000	O
g	O
on	O
day	O
3	O
with	O
aminoacids	O
,	O
lipids	O
-LRB-	O
Aminopäd	Brandname
10	Brandname
%	Brandname
,	O
Intralipid	Brandname
20	Brandname
%	Brandname
,	O
Baxter	Company
,	O
Erlangen	O
,	O
Germany	O
-RRB-	O
trace	O
elements	O
and	O
vitamins	O
-LRB-	O
Peditrace	Brandname
,	O
Soluvit	Brandname
N	Brandname
,	O
Vitintra	Brandname
,	O
Pharmacia-Upjohn	Company
GmbH	Company
,	O
Erlangen	O
,	O
Germany	O
-RRB-	O
.	O

Husbandry	O
and	O
apparent	O
metabolisable	O
energy	O
determination	O
Ross	O
308	O
female	O
chickens	O
were	O
obtained	O
from	O
a	O
commercial	O
hatchery	O
-LRB-	O
Grampian	Company
Ltd	Company
,	O
Whitburn	O
,	O
UK	O
-RRB-	O
at	O
1-d-old	O
and	O
were	O
placed	O
in	O
a	O
single	O
floor	O
pen	O
at	O
32	O
C.	O
DNA	O
was	O
extracted	O
by	O
the	O
method	O
of	O
Reguant	O
and	O
Bordons	O
-LRB-	O
2003	O
-RRB-	O
and	O
16S	O
rDNA	O
gene	O
was	O
amplified	O
in	O
a	O
thermocycler	Device
-LRB-	O
Techne	Company
LTD	Company
,	O
Cambridge	O
,	O
UK	O
-RRB-	O
using	O
the	O
primers	O
FD1	O
-LRB-	O
5	O
0	O
CAACAGAGTTTGATCCTGGCTCAG	O
3	O
0	O
-RRB-	O
and	O
RD1	O
-LRB-	O
5	O
0	O
GCTTAAGGAGGTGATCCAGCC	O
3	O
0	O
-RRB-	O
designed	O
by	O
Weisburg	O
et	O
al.	O
-LRB-	O
1991	O
-RRB-	O
.	O

Protein	O
extraction	O
and	O
Western	O
blot	O
The	O
VP	O
was	O
homogenized	O
using	O
a	O
Micro	Brandname
Dismembrator	Brandname
-LRB-	O
B.	Company
Braun	Company
Biotech	Company
International	Company
GmbH	Company
,	O
Melsungen	O
,	O
Germany	O
-RRB-	O
at	O
2000	O
rpm	O
for	O
45	O
sec	O
.	O

Tissues	O
were	O
then	O
added	O
to	O
an	O
adequate	O
amount	O
of	O
lysis	O
buffer	O
containing	O
either	O
0.5	O
%	O
Nonidet	O
P-40	O
-LRB-	O
NP-40	O
;	O
mice	O
tissues	O
-RRB-	O
,	O
0.5	O
%	O
NaDOC	O
,	O
0.1	O
%	O
SDS	O
,	O
50	O
mm	O
Tris-HCl	O
-LRB-	O
pH	O
7.5	O
-RRB-	O
,	O
150	O
mm	O
NaCl	O
,	O
1	O
mm	O
EDTA	O
-LRB-	O
pH	O
8.0	O
-RRB-	O
,	O
1	O
mm	O
NaF	O
,	O
and	O
Complete	Brandname
Protease	Brandname
Inhibitor	Brandname
Cocktail	Brandname
-LRB-	O
Roche	Company
Molecular	Company
Biochemicals	O
,	O
Mannheim	O
,	O
Germany	O
-RRB-	O
,	O
or	O
alternatively	O
,	O
7	O
m	O
urea	O
-LRB-	O
rat	O
tissues	O
-RRB-	O
,	O
2	O
m	O
thio-urea	O
,	O
4	O
%	O
3	O
-	O
-LSB-	O
-LRB-	O
3-cholamidopropyl	O
-RRB-	O
dimethylammonio	O
-RSB-	O
-1	O
propanesulfonate	O
,	O
and	O
30	O
mm	O
Tris	O
-LRB-	O
pH	O
8.5	O
-RRB-	O
.	O

Laser	O
Doppler	O
perfusion	O
imaging	O
Skin	O
microvascular	O
perfusion	O
was	O
measured	O
at	O
the	O
drug	O
delivery	O
site	O
using	O
a	O
laser	Device
Doppler	Device
imager	Device
-LRB-	O
MoorLDI	Brandname
,	O
Moor	Company
Instruments	Company
Ltd	Company
,	O
Devon	O
,	O
UK	O
-RRB-	O
.	O

A	O
2	O
mW	O
helium-neon	Device
laser	Device
scans	O
the	O
surface	O
of	O
the	O
skin	O
,	O
and	O
light	O
back-scattered	O
from	O
moving	O
erythrocytes	O
is	O
F	O
.	O

The	O
average	O
size	O
and	O
size	O
distribution	O
of	O
the	O
dry	O
nanoparticles	O
were	O
determined	O
by	O
measuring	O
the	O
diameter	O
of	O
more	O
than	O
100	O
particles	O
with	O
the	O
image	Device
analysis	Device
software	Device
AnalySIS	Brandname
Auto	Brandname
-LRB-	O
Soft	Company
Imaging	Company
System	Company
GmbH	Company
,	O
Germany	O
-RRB-	O
.	O

Hydrodynamic	O
diameter	O
and	O
size	O
distribution	O
of	O
the	O
nanoparticles	O
dispersed	O
in	O
an	O
aqueous	O
phase	O
were	O
measured	O
using	O
a	O
particle	Device
analyzer	Device
,	O
model	O
NANOPHOX	Brandname
-LRB-	O
Sympatec	Company
GmbH	Company
,	O
Germany	O
-RRB-	O
.	O

Lowary	O
-LRB-	O
University	O
of	O
Alberta	O
-RRB-	O
.	O

L7	O
,	O
MW	O
707.63	O
Da	O
-RRB-	O
were	O
purchased	O
from	O
IsoSep	Company
AB	Company
-LRB-	O
Sweden	O
-RRB-	O
.	O

The	O
structure	O
of	O
each	O
ligand	O
is	O
shown	O
in	O
Figure	O
S1	O
in	O
the	O
Supporting	O
Information	O
.	O

Half	O
of	O
each	O
supernatant	O
was	O
incubated	O
overnight	O
at	O
378C	O
with	O
an	O
equal	O
volume	O
of	O
pH	O
4.5	O
buffer	O
-LRB-	O
0.2	O
M	O
sodium	O
acetate	O
-RRB-	O
in	O
the	O
presence	O
of	O
10	O
U	O
almond	O
b-glucosidase	O
EC	O
3.2.1.21	O
-LRB-	O
NBS	Company
Biologicals	Company
Ltd.	Company
,	O
Huntingdon	O
,	O
UK	O
-RRB-	O
.	O

The	O
two	O
sample	O
fractions	O
were	O
each	O
partitioned	O
at	O
pH	O
2	O
against	O
an	O
equal	O
volume	O
of	O
ethylacetate	O
,	O
which	O
was	O
back	O
washed	O
against	O
H	O
2	O
O	O
and	O
then	O
reduced	O
to	O
dryness	O
by	O
rotary	O
evaporation	O
at	O
258C	O
.	O

Cells	O
were	O
counted	O
on	O
a	O
semi	Device
automated	Device
microcell	Device
counter	Device
-LRB-	O
F-800	Brandname
;	O
Sysmex	Company
GmbH	Company
,	O
Norderstedt	O
,	O
Germany	O
-RRB-	O
using	O
the	O
instructions	O
of	O
the	O
manufacturer	O
.	O

PGFE	O
PFGE	O
was	O
performed	O
using	O
the	O
previously	O
described	O
protocol	O
for	O
Salmonella	O
-LSB-	O
7,37	O
-RSB-	O
with	O
modifications	O
:	O
Strains	O
were	O
cultured	O
overnight	O
at	O
30	O
°C	O
on	O
R1-agar	O
and	O
suspended	O
in	O
CBS-buffer	O
-LRB-	O
100	O
mM	O
Tris	O
:	O
100	O
MM	O
EDTA	O
,	O
pH	O
8.0	O
-RRB-	O
to	O
a	O
final	O
turbidity	O
of	O
0.38-0.39	O
at	O
A	O
480	O
.	O

Lysozyme	O
-LRB-	O
Roche	Company
Diagnostics	Company
GmbH	Company
,	O
Mannheim	O
,	O
Germany	O
-RRB-	O
was	O
added	O
to	O
the	O
400	O
μl	O
bacterial	O
suspensions	O
to	O
reach	O
a	O
final	O
concentration	O
of	O
1	O
mg/ml	O
.	O

In	O
this	O
context	O
,	O
consideration	O
could	O
probably	O
be	O
given	O
to	O
meeting	O
the	O
needs	O
of	O
patient	O
subpopulations	O
with	O
a	O
particular	O
disease	O
modality	O
that	O
is	O
best	O
treated	O
by	O
inhalation	O
,	O
as	O
has	O
begun	O
recently	O
with	O
a	O
range	O
of	O
different	O
jet	Device
nebulizers	Device
designed	O
with	O
features	O
specifically	O
for	O
use	O
by	O
infants	O
,	O
toddlers	O
and	O
preschool	O
children	O
-LRB-	O
LC	Brandname
®	Brandname
-	Brandname
Sprint	Brandname
,	O
PARI	Company
GmbH	Company
,	O
Germany	O
-RRB-	O
.	O

Efforts	O
are	O
also	O
continuing	O
to	O
develop	O
marketable	O
inhaled	O
insulin	O
for	O
systemic	O
delivery	O
by	O
inhalation	O
despite	O
the	O
failure	O
of	O
Exubera	Brandname
in	O
2007	O
,	O
and	O
the	O
use	O
of	O
the	O
lungs	O
as	O
a	O
gateway	O
organ	O
for	O
delivery	O
to	O
targets	O
elsewhere	O
in	O
the	O
body	O
will	O
probably	O
continue	O
.	O

Each	O
reaction	O
consists	O
of	O
2	O
µl	O
template	O
DNA	O
,	O
0.5	O
µl	O
of	O
each	O
primers	O
at	O
25	O
µM	O
,	O
1.25	O
µl	O
of	O
dNTP	O
-LRB-	O
BIORON	Company
GmbH	Company
,	O
Germany	O
-RRB-	O
at	O
5	O
mM	O
,	O
0.5	O
U	O
Taq	Brandname
DNA	Brandname
polymerase	Brandname
-LRB-	O
Roche	Company
Diagnostics	Company
GmbH	Company
,	O
Mannheim	O
,	O
Germany	O
-RRB-	O
and	O
5	O
µl	O
10	O
×	O
PCR	O
buffer	O
.	O

All	O
the	O
blood	O
pressure	O
measurements	O
were	O
undertaken	O
with	O
an	O
automatic	O
oscillometric	Device
blood	Device
pressure	Device
recorder	Device
-LRB-	O
Dinamap	Brandname
,	O
Critikon	Company
Ltd	Company
,	O
Ascot	O
,	O
UK	O
-RRB-	O
.	O

The	O
resting	O
blood	O
pressure	O
was	O
measured	O
three	O
times	O
at	O
1-min	O
intervals	O
from	O
the	O
right	O
arm	O
after	O
the	O
patient	O
had	O
been	O
seated	O
for	O
at	O
least	O
5	O
min	O
.	O

Airflows	O
were	O
set	O
to	O
700	O
l/min	O
and	O
250	O
l/min	O
in	O
the	O
larger	O
and	O
the	O
smaller	O
chambers	O
,	O
respectively	O
-LRB-	O
Promethion	Brandname
FG	Brandname
1000	Brandname
and	O
FG	Brandname
250	Brandname
flow	Device
generators	Device
;	O
Sable	Company
Systems	Company
Europe	Company
GmbH	Company
,	O
Berlin	O
,	O
Germany	O
-RRB-	O
.	O

Chambers	O
were	O
operated	O
under	O
negative	O
pressure	O
-LRB-	O
−	O
60	O
Pa	O
-RRB-	O
compared	O
with	O
ambient	O
air	O
pressure	O
.	O

The	O
crystalline	O
status	O
was	O
determined	O
using	O
the	O
Di	Device
erential	Device
Scanning	Device
Calorimeter	Device
-LRB-	O
TA	Brandname
8500	Brandname
,	O
Mettler	Company
Toledo	Company
GmbH	Company
,	O
Gieû	O
en	O
,	O
Germany	O
-RRB-	O
.	O

Approximately	O
15	O
mg	O
of	O
the	O
samples	O
were	O
weighted	O
in	O
small	O
aluminium	Device
pans	Device
and	O
heated	O
from	O
258C	O
to	O
858C	O
with	O
a	O
scan	O
rate	O
of	O
5	O
K/min	O
.	O

.	O

,	O
Alken	O
,	O
Belgium	O
-RRB-	O
and	O
loaded	O
into	O
the	O
freeze	Device
dryer	Device
-LRB-	O
Model	O
Lyovac	Brandname
GT4	Brandname
,	O
GEA	Company
Lyophil	Company
GmbH	Company
,	Company
Hürth	O
,	O
Germany	O
-RRB-	O
.	O

Vials	O
were	O
frozen	O
to	O
−	O
35	O
°C	O
in	O
2	O
h.	O
Primary	O
drying	O
-LRB-	O
50	O
h	O
-RRB-	O
was	O
started	O
at	O
a	O
shelf	O
temperature	O
of	O
−	O
35	O
°C	O
and	O
a	O
chamber	O
pressure	O
of	O
0.4	O
mbar	O
.	O

Additionally	O
,	O
for	O
blocking	O
of	O
the	O
binding	O
of	O
antibodies	O
to	O
the	O
Fc	O
receptors	O
,	O
the	O
FcR	O
Blocking	O
Reagent	O
-LRB-	O
human	O
from	O
Miltenyi	Company
Biotec	Company
GmbH	Company
,	O
Germany	O
-RRB-	O
,	O
in	O
dilution	O
1:100	O
,	O
for	O
10	O
min	O
at	O
+4	O
°C	O
,	O
was	O
used	O
on	O
all	O
studied	O
sections	O
.	O

To	O
apply	O
uniaxial	O
strain	O
to	O
the	O
protein	O
film	O
,	O
one	O
T-piece	O
is	O
connected	O
to	O
a	O
piezoelectric	Device
motor	Device
unit	Device
-LRB-	O
IW-801	Brandname
,	O
Inchworm	O
single	O
axis	O
,	O
EXFO	Company
Burleigh	Company
,	O
Mississauga	O
,	O
Ontario	O
,	O
Canada	O
-RRB-	O
equipped	O
with	O
an	O
integral	Device
encoder	Device
stage	Device
-LRB-	O
TSE-150	Brandname
,	O
Exfo	Company
Burleigh	Company
-RRB-	O
attached	O
to	O
an	O
incremental	Device
linear	Device
encoder	Device
-LRB-	O
EXE	Brandname
650B	Brandname
,	O
Dr.	Company
Johannes	Company
Heidenhain	Company
GmbH	Company
,	O
Traunreut	O
,	O
Germany	O
-RRB-	O
.	O

The	O
absolute	O
accuracy	O
of	O
stage	O
and	O
encoder	O
is	O
1	O
µm	O
.	O

Confocal	O
laser	O
scanning	O
microscopic	O
imaging	O
was	O
performed	O
using	O
a	O
Leica	O
confocal	Device
microscope	Device
-LRB-	O
TCSSPE	Brandname
,	O
Leica	Company
Microsystems	Company
CMS	Company
GmbH	Company
,	O
Mannheim	O
,	O
Germany	O
-RRB-	O
.	O

Statistical	O
assay	O
Student	O
's	O
t-test	O
and	O
Fisher	O
's	O
exact	O
test	O
were	O
used	O
for	O
statistical	O
analysis	O
.	O


-DOCSTART- O

Pen-like	O
devices	O
-LRB-	O
Sniffin	Brandname
'	Brandname
Sticks	Brandname
;	O
Burghart	Company
Gmbh	Company
,	O
Germany	O
-RRB-	O
were	O
filled	O
with	O
7	O
mL	O
of	O
each	O
diluted	O
solution	O
and	O
coded	O
with	O
a	O
three-digit	O
number	O
.	O

The	O
proteins	O
were	O
purified	O
to	O
>	O
95	O
%	O
by	O
HPLC	O
using	O
a	O
Vydac	Brandname
®	Brandname
reverse	Brandname
phase	Brandname
HPLC	Brandname
C4	Brandname
Mass	Brandname
Spec	Brandname
214MS54	Brandname
column	O
-LRB-	O
Grace	Company
Silica	Company
GmbH	Company
,	O
Düren	O
,	O
Germany	O
-RRB-	O
.	O

NMR	O
data	O
acquisition	O
The	O
mutants	O
of	O
ubiquitin	O
samples	O
were	O
prepared	O
for	O
NMR	O
experiments	O
by	O
subsequent	O
dialysis	O
against	O
50	O
mM	O
sodium	O
phosphate	O
buffer	O
at	O
pH	O
5.8	O
-LRB-	O
90	O
%	O
H	O
2	O
O	O
,	O
10	O
%	O
D	O
2	O
O	O
-RRB-	O
.	O

RNA	O
Extraction	O
and	O
Real	O
Time	O
RT-PCR	O
Screening	O
of	O
the	O
Samples	O
In	O
the	O
laboratory	O
,	O
the	O
samples	O
were	O
vortex-mixed	O
and	O
centrifuged	O
at	O
1000	O
rpm	O
for	O
10	O
min	O
following	O
which	O
140	O
ml	O
of	O
supernatant	O
was	O
used	O
for	O
the	O
extraction	O
of	O
viral	O
RNA	O
using	O
commercially	O
available	O
QIAamp	Brandname
Viral	Brandname
RNA	Brandname
Mini	Brandname
Kit	Device
-LRB-	O
Qiagen	Company
GmbH	Company
,	O
Hilden	O
,	O
Germany	O
-RRB-	O
as	O
per	O
the	O
manufacturer	O
's	O
instructions	O
.	O

Transwells	Brandname
were	O
mounted	O
with	O
DAPI	O
fluorescent	O
mounting	O
media	O
-LRB-	O
Vector	Company
Laboratories	Company
Ltd.	Company
,	O
Peterborough	O
,	O
UK	O
-RRB-	O
and	O
left	O
overnight	O
at	O
4	O
°C	O
before	O
analysis	O
using	O
a	O
spinning	Device
disk	Device
confocal	Device
microscope	Device
with	O
Volocity	Brandname
software	Brandname
-LRB-	O
Version	O
5.5	O
,	O
PerkinElmer	Company
,	O
Cambridge	O
,	O
UK	O
-RRB-	O
.	O

.	O

,	O
USA	O
-RRB-	O
,	O
1	O
%	O
Penicillin-Streptomycin	O
-LRB-	O
PAA	Company
,	Company
Laboratories	Company
GmbH	Company
,	O
Austria	O
-RRB-	O
and	O
1	O
%	O
Amphotericin	O
B	O
-LRB-	O
PAA	Company
,	Company
Laboratories	Company
GmbH	Company
,	O
Austria	O
-RRB-	O
.	O

The	O
cells	O
were	O
maintained	O
at	O
37	O
°C	O
in	O
95	O
%	O
relative	O
humidified	O
atmosphere	O
containing	O
5	O
%	O
CO	O
2	O
.	O

A	O
Nikon	Brandname
Ti-E	Brandname
microscope	Brandname
Nikon	Company
Instruments	Company
Europe	Company
B.V.	Company
,	O
Amstelveen	O
,	O
The	O
Netherlands	O
,	O
equipped	O
with	O
an	O
APO-TIRFM	Device
lens	Device
60	Device
,	O
numerical	O
aperture	O
of	O
1.49	O
with	O
oil	O
immersion	O
,	O
working	O
distance	O
of	O
0.12	O
mm	O
,	O
and	O
refractive	O
index	O
of	O
immersion	O
oil	O
of	O
1.51	O
was	O
used	O
along	O
with	O
a	O
TIRFM	Device
laser	Device
beam	Device
position	Device
manipulator	Device
controlled	O
using	O
the	O
``	O
NIKON	Brandname
TI	Brandname
CONTROL	Brandname
''	O
software	Device
.	O

Samples	O
from	O
liver	O
,	O
kidney	O
,	O
gills	O
,	O
head	O
kidney	O
,	O
skin	O
,	O
adipose	O
tissue	O
,	O
heart	O
and	O
dorsal	O
fin	O
were	O
sliced	O
and	O
immediately	O
placed	O
in	O
RNAlater	O
-LRB-	O
Qiagen	Company
GmbH	Company
,	O
Hilden	O
,	O
Germany	O
-RRB-	O
,	O
following	O
the	O
supplier	O
's	O
protocol	O
.	O

Animals	O
for	O
the	O
stocking	O
density	O
experiment	O
were	O
bred	O
in	O
a	O
recirculation	O
system	O
with	O
brackish	O
water	O
in	O
the	O
Institute	O
for	O
Fisheries	O
in	O
Born	O
,	O
Germany	O
.	O

Fungal	O
genomic	O
DNA	O
was	O
isolated	O
as	O
described	O
by	O
Cenis	O
-LRB-	O
1992	O
-RRB-	O
and	O
plasmid	O
DNA	O
was	O
isolated	O
using	O
a	O
plasmid	Brandname
DNA	Brandname
preparation	Brandname
kit	Brandname
-LRB-	O
Qiagen	Company
GmbH	Company
,	O
Hilden	O
,	O
Germany	O
-RRB-	O
.	O

Fungal	O
genomic	O
DNA	O
and	O
lambda	O
DNA	O
was	O
transferred	O
to	O
Amersham	Brandname
Hybond-N	Brandname
+	Brandname
filters	Brandname
-LRB-	O
GE	Company
Healthcare	Company
Limited	Company
,	O
Freiburg	O
,	O
Germany	O
-RRB-	O
after	O
digestion	O
with	O
restriction	O
enzymes	O
and	O
size	O
separation	O
on	O
a	O
1	O
%	O
agarose	O
gel	O
according	O
to	O
Sambrook	O
and	O
associates	O
-LRB-	O
1989	O
-RRB-	O
.	O

Each	O
time	O
,	O
the	O
wooden	O
cylinders	O
were	O
presented	O
to	O
the	O
investigators	O
in	O
randomized	O
order	O
based	O
on	O
a	O
random	O
treatment	O
allocation	O
plan	O
generated	O
before	O
initiation	O
of	O
the	O
trial	O
by	O
using	O
the	O
random	O
number	O
function	O
of	O
Excel	Brandname
-LRB-	O
Microsoft	Brandname
Office	Brandname
2003	Brandname
,	O
Microsoft	Company
Deutschland	Company
GmbH	Company
,	O
Munich	O
,	O
Germany	O
-RRB-	O
.	O

The	O
investigators	O
were	O
divided	O
into	O
2	O
groups	O
.	O

Surgical	O
Results	O
All	O
patients	O
had	O
a	O
TMD	O
as	O
described	O
by	O
Regan	O
et	O
aP	O
and	O
Rosenthal	O
et	O
al	O
,	O
'	O
''	O
*	O
using	O
30	Device
°	Device
optics	Device
-LRB-	O
Karl	Company
Storz	Company
GmbH	Company
&	Company
Co.	Company
,	O
Tuttlingen	O
,	O
Germany	O
-RRB-	O
and	O
a	O
pneumatic	Device
arm	Device
holding	O
the	O
endoscope	Device
-LRB-	O
Geyser	Company
S.A.	Company
,	O
Coudes	O
,	O
France	O
-RRB-	O
.	O

Finally	O
,	O
NR	O
was	O
extracted	O
from	O
the	O
lysosomes	O
using	O
400	O
μL	O
of	O
an	O
extraction	O
solution	O
-LRB-	O
1	O
%	O
v/v	O
acetic	O
acid	O
and	O
50	O
%	O
v/v	O
ethanol	O
-RRB-	O
and	O
gently	O
shaken	O
on	O
a	O
horizontal	Device
shaker	Device
-LRB-	O
TiMix	Brandname
2	Brandname
,	O
Johanna	Company
Otto	Company
GmbH	Company
,	O
Hechingen	O
,	O
Germany	O
-RRB-	O
for	O
10	O
min	O
.	O

NR	O
fluorescence	O
was	O
measured	O
at	O
excitation/emission	O
wavelengths	O
of	O
530/645	O
nm	O
using	O
the	O
same	O
plate	Device
reader	Device
.	O

The	O
oil	O
and	O
aqueous	O
phases	O
were	O
then	O
mixed	O
together	O
108	O
with	O
an	O
UltraTurrax	Brandname
®	Brandname
T25	Brandname
homogeniser	Brandname
-LRB-	O
IKA	Company
®	Company
-	Company
Werke	Company
GmbH	Company
&	Company
Co.	Company
.	Company

KG	O
,	O
Germany	O
-RRB-	O
.	O

In	O
order	O
to	O
109	O
avoid	O
bias	O
the	O
order	O
of	O
preparation	O
of	O
the	O
batches	O
was	O
random	O
.	O

110	O
Droplet	O
size	O
analysis	O
111	O
The	O
emulsions	O
were	O
analyzed	O
for	O
droplet	O
size	O
using	O
an	O
optical	Device
microscope	Device
equipped	O
with	O
an	O
USB	Device
112	Device
video	Device
camera	Device
-LRB-	O
Bresser	Company
,	O
Germany	O
-RRB-	O
.	O

Data	O
Coding	O
Visual	O
attention	O
to	O
the	O
video	O
during	O
the	O
learning	O
phase	O
and	O
the	O
recognition	O
memory	O
tests	O
was	O
analyzed	O
using	O
SMI	Brandname
BeGaze	Brandname
software	Brandname
-LRB-	O
SensoMotoric	Company
Instruments	Company
GmbH	Company
,	O
Germany	O
-RRB-	O
.	O

In	O
the	O
current	O
literature	O
,	O
there	O
is	O
no	O
standard	O
definition	O
for	O
fixations	O
,	O
which	O
have	O
been	O
defined	O
as	O
anywhere	O
between	O
50	O
and	O
250	O
ms	O
-LRB-	O
for	O
discussion	O
,	O
see	O
Holmqvist	O
et	O
al.	O
,	O
2011	O
-RRB-	O
.	O

Physiological	O
experiments	O
were	O
performed	O
in	O
50	O
ml	O
minimal	O
medium	O
-LRB-	O
pH	O
5.2	O
-RRB-	O
containing	O
1.6	O
g	O
l	O
-1	O
NH	O
4	O
Cl	O
,	O
0.5	O
g	O
l	O
-1	O
KH	O
2	O
PO	O
4	O
,	O
0.2	O
g	O
l	O
-1	O
MgSO	O
4	O
,	O
0.17	O
g	O
l	O
-1	O
FeSO	O
4	O
and	O
20	O
g	O
l	O
-1	O
of	O
varying	O
carbon	O
sources	O
such	O
as	O
xylan	O
from	O
birch	Device
wood	Device
-LRB-	O
Carl	Company
Roth	Company
GmbH	Company
,	O
Germany	O
-RRB-	O
,	O
glucose	O
and	O
xylose	O
in	O
500	O
ml	O
Erlenmeyer	Device
flasks	Device
at	O
28	O
°C	O
and	O
150	O
rpm	O
.	O

The	O
total	O
crude	O
fat	O
in	O
MPI	O
was	O
determined	O
from	O
freeze-dried	O
MPI	O
by	O
extracting	O
approximately	O
1.0	O
g	O
of	O
the	O
dry	O
MPI	O
with	O
20	O
mL	O
of	O
petroleum	O
ether	O
for	O
4	O
h	O
using	O
a	O
Soxtec	Brandname
1043	Brandname
extraction	Brandname
unit	Brandname
-LRB-	O
Tecator	Company
AB	Company
,	O
Höganäs	O
,	O
Sweden	O
-RRB-	O
.	O

After	O
extraction	O
,	O
the	O
solvent	O
was	O
evaporated	O
at	O
21	O
°C	O
in	O
a	O
fume	O
hood	O
.	O

BSEP	O
antibodies	O
were	O
raised	O
in	O
the	O
rabbit	O
and	O
generated	O
by	O
the	O
antibody	O
generation	O
group	O
at	O
AstraZeneca	Company
Ltd.	Company
,	O
UK	O
-LRB-	O
antibody	O
clone	O
H3310	O
-RRB-	O
and	O
used	O
at	O
a	O
dilution	O
of	O
1:50	O
.	O

Nodules	O
and	O
other	O
major	O
cell	O
aggregates	O
were	O
visualized	O
as	O
dark	O
spots	O
before	O
a	O
clear	O
background	O
using	O
an	O
electronic	Device
camera	Device
system	Device
-LRB-	O
Phase	Company
GmbH	Company
,	O
Lübeck	O
,	O
Germany	O
-RRB-	O
operating	O
at	O
maximum	O
contrast	O
.	O

Spot	O
staining	O
was	O
quantified	O
using	O
Gel-Pro	Brandname
Analyzer	Brandname
3.1	Brandname
software	Brandname
-LRB-	O
Media	Company
Cybernetics	Company
,	O
Silver	O
Spring	O
,	O
MD	O
,	O
USA	O
-RRB-	O
.	O

Spatial	O
co-ordinates	O
for	O
the	O
determination	O
of	O
kinematic	O
data	O
were	O
collected	O
using	O
an	O
ultrasound-based	Brandname
zebris	Brandname
CMS-HS	Brandname
system	Brandname
-LRB-	O
ZEBRIS	Company
,	O
Medizintechnik	O
GmbH	O
,	O
Germany	O
-RRB-	O
.	O

The	O
measuring	O
heads	O
were	O
positioned	O
behind	O
the	O
individual	O
-LRB-	O
Fig.	O
1	O
-RRB-	O
.	O

Gas	O
concentration	O
-LRB-	O
SF	O
6	O
and	O
CH	O
4	O
-RRB-	O
in	O
breath	O
and	O
ambient	O
air	O
was	O
determined	O
using	O
a	O
gas	Device
chromatograph	Device
-LRB-	O
CP-9003	Brandname
,	O
Varian-Chrompack	Company
,	O
Les	O
Ulis	O
,	O
France	O
-RRB-	O
fitted	O
with	O
an	O
electron	Device
capture	Device
detector	Device
-LRB-	O
Autosystem	Brandname
XL	Brandname
,	O
Perkin	Company
Elmer	Company
Instruments	Company
,	O
Courtaboeuf	O
,	O
France	O
-RRB-	O
equipped	O
with	O
a	O
Molecular	Device
Sieve	Device
0.5-nm	Device
column	Device
-LRB-	O
3	O
m	O
×	O
3.2	O
mm	O
i.d	O
;	O
Interchim	Company
,	O
Montluçon	O
,	O
France	O
-RRB-	O
maintained	O
at	O
50	O
°C	O
for	O
SF	O
6	O
,	O
or	O
fitted	O
with	O
a	O
flame-ionization	Device
detector	Device
and	O
equipped	O
with	O
a	O
Porapak	Brandname
N	Brandname
80-100	Brandname
mesh	Brandname
column	Brandname
-LRB-	O
3	O
m	O
×	O
3.2	O
mm	O
i.d.	O
;	O
Alltech	Company
France	Company
SARL	Company
,	O
Templemars	O
,	O
France	O
-RRB-	O
maintained	O
at	O
40	O
°C	O
for	O
CH	O
4	O
.	O

The	O
flow	O
rate	O
of	O
the	O
carrier	Device
gas	Device
was	O
30	O
mL/min	O
of	O
N	O
2	O
for	O
SF	O
6	O
and	O
40	O
mL/min	O
of	O
helium	O
for	O
CH	O
4	O
.	O

Due	O
to	O
technical	O
faults	O
we	O
lost	O
or	O
disregarded	O
as	O
evident	O
outliers	O
the	O
measurements	O
of	O
PTR-ToF-MS	O
Analysis	O
Measurements	O
were	O
performed	O
with	O
a	O
commercial	O
PTR-ToF	Device
8000	Device
instrument	Device
-LRB-	O
Ionicon	Company
Analytik	Company
GmbH	Company
,	O
Innsbruck	O
,	O
Austria	O
-RRB-	O
with	O
the	O
Time	O
of	O
Flight	O
analyser	O
operated	O
in	O
V	O
mode	O
.	O


-DOCSTART- O

The	O
instrument	O
was	O
an	O
Elzone	Brandname
model	Brandname
8OXY	Brandname
-LRB-	O
Particle	Company
Data	Company
Ltd.	Company
,	O
Cheltenham	O
,	O
Gloucs.	O
,	O
UK	O
-RRB-	O
.	O

The	O
analyzer	Device
was	O
fitted	O
with	O
a	O
30-pm	O
orifice	O
tube	O
and	O
calibrated	O
using	O
latex	O
standards	O
of	O
sizes	O
2.02	O
,	O
5.00	O
,	O
and	O
10.18	O
p	O
m	O
to	O
give	O
a	O
size	O
range	O
1.00-15.01	O
p	O
m	O
divided	O
into	O
128	O
channels	O
.	O

Statistical	O
analysis	O
Multivariate	O
analysis	O
:	O
OPLS-DA	O
Orthogonal	O
projections	O
to	O
latent	O
structures	O
discriminant	O
analysis	O
-LRB-	O
OPLS-DA	O
-RRB-	O
was	O
performed	O
in	O
SIMCA-P	Brandname
?	O

12.0	O
-LRB-	O
Umetrics	Company
AB	Company
,	O
Umeå	O
,	O
Sweden	O
-RRB-	O
on	O
mean	O
centered	O
and	O
unit	O
variance	O
scaled	O
metabolite	O
responses	O
from	O
the	O
original	O
data	O
set	O
.	O

To	O
visualize	O
double-stranded	O
DNA	O
,	O
sections	O
were	O
counterstained	O
with	O
DAPI	O
-LRB-	O
10236276001	O
,	O
1:1,000	O
-RRB-	O
-LRB-	O
Roche	Company
Diagnostics	Company
GmbH	Company
,	O
Mannheim	O
,	O
Germany	O
-RRB-	O
for	O
10	O
min	O
.	O

Finally	O
,	O
sections	O
were	O
mounted	O
with	O
glass	O
coverslips	O
using	O
Fluorescent	O
Mounting	O
Medium	O
-LRB-	O
DAKO	Company
Ltd	Company
,	O
Cambridgeshire	O
,	O
UK	O
-RRB-	O
.	O

Flow	O
cytometry	O
was	O
performed	O
on	O
a	O
Dako	Brandname
CyAn	Brandname
ADP	Device
platform	Device
-LRB-	O
Beckman-Coulter	Company
Ltd.	Company
,	O
UK	O
-RRB-	O
and	O
analyzed	O
using	O
Summit	Brandname
v4	Brandname
.3	Brandname
software	Device
.	O

Isolation	O
and	O
culture	O
of	O
BMDC/BMM	O
BMDC	O
were	O
prepared	O
by	O
culturing	O
bone	O
marrow	O
cells	O
obtained	O
from	O
the	O
femurs	O
and	O
tibia	O
of	O
mice	O
in	O
RPMI	O
1640	O
medium	O
in	O
the	O
presence	O
of	O
granulocyte	O
macrophage-colony	O
stimulating	O
factor	O
-LRB-	O
GM-CSF	O
-RRB-	O
-LRB-	O
50	O
ng/mL	O
-RRB-	O
.	O

For	O
chromatography	O
,	O
heparin-agarose	O
was	O
purchased	O
from	O
Sigma	Company
,	O
and	O
diethylaminoethyl	O
-LRB-	O
DEAE	O
-RRB-	O
-	O
Sephacel	O
and	O
carboxymethyl	O
-LRB-	O
CM	O
-RRB-	O
-	O
Sepharose	O
were	O
purchased	O
from	O
Pharmacia	Company
AB	Company
-LRB-	O
Uppsala	O
,	O
Sweden	O
-RRB-	O
.	O

For	O
immunohistochemical	O
staining	O
,	O
an	O
avidin-biotin-horseradish	Device
peroxidase	Device
complex	Device
system	Device
-LRB-	O
Vectastain	Brandname
,	O
Vector	Company
Lab.	Company
,	O
Burlingame	O
,	O
CA	O
-RRB-	O
was	O
used	O
with	O
3,3	O
'	O
-	O
diaminobenzidine	O
as	O
substrate	O
;	O
specific	O
rabbit	O
polyclonal	O
antibody	O
for	O
HBGF-1	O
-LRB-	O
no.	O
06-101	O
-RRB-	O
was	O
purchased	O
from	O
Upstate	Company
Biotechnology	Company
-LRB-	O
Lake	O
Placid	O
,	O
NY	O
-RRB-	O
;	O
and	O
specific	O
rabbit	O
polyclonal	O
antibody	O
for	O
HBGF-2	O
was	O
obtained	O
from	O
A.	O
NIR	O
fluorescence	O
emission	O
at	O
700	O
nm	O
was	O
collected	O
and	O
detected	O
with	O
a	O
fast	Device
photomultiplier	Device
tube	Device
-LRB-	O
Hamamatsu	Company
,	O
Japan	O
-RRB-	O
and	O
time-correlated	O
single	Device
photon	Device
counting	Device
system	Device
-LRB-	O
Becker	Company
and	Company
Hickl	Company
GmbH	Company
,	O
Berlin	O
,	O
Germany	O
-RRB-	O
.	O

In	O
vivo	O
magnetic	O
resonance	O
images	O
were	O
obtained	O
using	O
a	O
MRI	Device
scanner	Device
at	O
3.0-T	O
field	O
strength	O
-LRB-	O
Tim	Brandname
Trio	Brandname
;	O
Siemens	Company
,	O
Erlangen	O
,	O
Germany	O
-RRB-	O
,	O
after	O
the	O
probe	O
was	O
intravenously	O
injected	O
into	O
the	O
mice	O
prepared	O
as	O
described	O
above	O
.	O

Animals	O
received	O
humane	O
care	O
in	O
compliance	O
with	O
the	O
Principles	O
of	O
Laboratory	O
Animal	O
Care	O
formuAnimals	O
were	O
premedicated	O
with	O
an	O
intramuscular	O
injection	O
of	O
0.1-0.5	O
mg/kg	O
xylazin	O
-LRB-	O
Rompun	O
2	O
%	O
,	O
Bayer	O
lated	O
by	O
the	O
National	O
Society	O
for	O
Medical	O
Research	O
and	O
the	O
Guide	O
for	O
the	O
Care	O
and	O
Use	O
of	O
Laboratory	O
Animals	O
Vital	O
GmbH	O
,	O
Leverkusen	O
,	O
Germany	O
-RRB-	O
and	O
10-20	O
mg/kg	O
Ketamin	O
10	O
%	O
-LRB-	O
Bela-Pharm	O
GmbH	O
&	O
Co.	O
.	O

The	O
ability	O
of	O
the	O
fibroblasts	O
to	O
contract	O
the	O
floating	O
gels	O
was	O
determined	O
by	O
quantifying	O
the	O
area	O
of	O
the	O
gels	O
daily	O
using	O
an	O
LAS4000	Brandname
image	Device
analyzer	Device
-LRB-	O
GE	Company
Healthcare	Company
Bio-Science	Company
AB	Company
,	O
Uppsela	O
,	O
Sweden	O
-RRB-	O
.	O

Data	O
are	O
expressed	O
as	O
the	O
percentage	O
of	O
gel	O
area	O
compared	O
with	O
the	O
original	O
gel	O
size	O
.	O

Each	O
expansion	O
medium	O
was	O
supplemented	O
with	O
5	O
%	O
human	O
serum	O
type	O
AB	O
-LRB-	O
Biochrom	Company
AG	Company
,	O
Berlin	O
,	O
Germany	O
-RRB-	O
and	O
1000	O
IU/ml	O
of	O
IL-2	O
-LRB-	O
Proleukin	Brandname
S	Brandname
,	O
Novartis	O
Pharma	Company
GmbH	Company
,	O
Nürnberg	O
,	O
Germany	O
-RRB-	O
.	O

In	O
addition	O
,	O
NK	O
MACS	O
contained	O
2	O
%	O
NK	Brandname
MACS	Brandname
supplement	Brandname
®	Brandname
-LRB-	O
Miltenyi	Company
Biotec	Company
,	O
Bergisch	O
Gladbach	O
,	O
Germany	O
-RRB-	O
.	O

Hindlimb	O
ischemia	O
was	O
induced	O
by	O
ligating	O
the	O
right	O
femoral	O
artery	O
and	O
blood	O
flow	O
of	O
the	O
ischemic	O
limb	O
was	O
estimated	O
with	O
a	O
laser	Device
Doppler	Device
perfusion	Device
imager	Device
-LRB-	O
LDPI	Device
;	O
Moor	Company
Instruments	Company
Ltd.	Company
,	Company
Devon	O
,	O
UK	O
-RRB-	O
to	O
confirm	O
the	O
angiogenic	O
effect	O
of	O
AM-Tg	O
mice	O
.	O

For	O
analysis	O
of	O
gel	O
electrophoresis	O
the	O
Blue	Brandname
Light	Brandname
Table	Brandname
and	O
Stain	Brandname
Clear	Brandname
G	Brandname
were	O
used	O
,	O
purchased	O
from	O
Serva	Company
Electrophoresis	Company
GmbH	Company
-LRB-	O
Heidelberg	O
,	O
Germany	O
-RRB-	O
.	O

All	O
oligonucleotides	O
were	O
synthesised	O
by	O
Eurofins	Company
Genomics	Company
-LRB-	O
Ebersberg	O
,	O
Germany	O
-RRB-	O
,	O
purchased	O
in	O
lyophilized	O
form	O
and	O
dissolved	O
in	O
nuclease-free	O
water	O
.	O

Light	O
emission	O
of	O
the	O
samples	O
were	O
measured	O
by	O
a	O
luminometer	Device
-LRB-	O
Berthold	Company
Detection	Company
Systems	Company
,	O
GmbH	O
,	O
Germany	O
-RRB-	O
.	O

The	O
residual	O
activities	O
were	O
plotted	O
versus	O
urea	O
concentration	O
.	O

The	O
electrospray	O
ionization	O
-LRB-	O
ESI	O
-RRB-	O
mass	O
spectrometry	O
experiments	O
were	O
performed	O
on	O
an	O
Electronspray	Brandname
MS-LCQDeca	Brandname
-LRB-	O
Thermo	Company
Finnigan	Company
Ltd.	Company
,	O
Hertfordshire	O
,	O
UK	O
-RRB-	O
,	O
low	O
flow	O
,	O
and	O
mass	Device
spectrometer	Device
.	O

Samples	O
were	O
dissolved	O
in	O
a	O
small	O
volume	O
of	O
HPLC	O
grade	O
methanot/water	O
-LRB-	O
70:30	O
,	O
v/v	O
-RRB-	O
0.01	O
M	O
in	O
ammonium	O
acetate	O
.	O

The	O
binding	O
of	O
the	O
secondary	O
antibody	O
was	O
detected	O
with	O
peroxidase-labelled	O
sheep	O
anti-human	O
IgG	O
-LRB-	O
The	Company
Binding	Company
Site	Company
Ltd	Company
,	O
Birmingham	O
UK	O
-RRB-	O
.	O

Serum	O
IgG	O
titres	O
from	O
individual	O
animals	O
were	O
calculated	O
from	O
the	O
standard	O
curve	O
as	O
mg	O
of	O
specific	O
IgG	O
per	O
mL	O
serum	O
,	O
using	O
Titretek	Brandname
software	Device
from	O
which	O
geometric	O
mean	O
titres	O
-LRB-	O
GMT	O
-RRB-	O
and	O
standard	O
errors	O
of	O
the	O
mean	O
-LRB-	O
sem	O
-RRB-	O
were	O
determined	O
per	O
treatment	O
group	O
.	O

Materials	O
CSA	O
-LRB-	O
Novartis	Company
Pharma	Company
,	O
AG	O
,	O
Basel	O
,	O
Switzerland	O
-RRB-	O
,	O
Indo	O
-LRB-	O
European	Company
Egyptian	Company
Pharmaceutical	Company
Industries	Company
,	O
Alexandria	O
,	O
Egypt	O
-RRB-	O
,	O
cremophor	O
EL	O
-LRB-	O
Sigma-Aldrich	Company
,	O
MO	O
,	O
USA	O
-RRB-	O
and	O
thiopental	O
sodium	O
-LRB-	O
Biochemie	Company
GmbH	Company
,	O
Vienna	O
,	O
Austria	O
-RRB-	O
were	O
purchased	O
from	O
commercial	O
vendors	O
.	O

Data	O
processing	O
was	O
carried	O
out	O
using	O
Proteome	Brandname
Discoverer	Brandname
1.4	Brandname
-LRB-	O
Thermo	Company
Scientific	Company
-RRB-	O
,	O
and	O
database	O
searching	O
was	O
conducted	O
on	O
an	O
inhouse	O
installation	O
of	O
Mascot	Brandname
Server	Brandname
2.5	Brandname
-LRB-	O
Matrix	Company
Science	Company
Ltd.	Company
;	O
London	O
,	O
United	O
Kingdom	O
-RRB-	O
.	O

Mascot	O
settings	O
were	O
as	O
follows	O
:	O
precursor	O
mass	O
tolerance	O
,	O
3	O
ppm	O
;	O
fragment	O
mass	O
tolerance	O
,	O
0.5	O
Da	O
;	O
maximum	O
missed	O
cleavage	O
sites	O
,	O
2	O
;	O
ion	O
score	O
or	O
expected	O
cut-off	O
,	O
20	O
;	O
significance	O
threshold	O
,	O
P	O
<	O
0.01	O
;	O
cysteine	O
carbamidomethylation	O
-LRB-	O
CAM-C	O
-RRB-	O
was	O
chosen	O
as	O
fixed	O
posttranslational	O
modification	O
-LRB-	O
PTM	O
-RRB-	O
,	O
whereas	O
methionine	O
oxidation	O
-LRB-	O
Met-Ox	O
-RRB-	O
was	O
chosen	O
as	O
variable	O
PTM	O
.	O

On	O
day	O
2	O
,	O
samples	O
were	O
submerged	O
in	O
Tissue-Tek	Brandname
OCT	Brandname
compound	O
-LRB-	O
Sakura	Company
Finetek	Company
,	O
Torrance	O
,	O
CA	O
-RRB-	O
and	O
frozen	O
at	O
À	O
80	O
°C	O
before	O
being	O
sectioned	O
at	O
12	O
mm	O
on	O
a	O
Microm	Brandname
HM	Brandname
500	Brandname
M	Brandname
cryostat	Brandname
-LRB-	O
Microm	Company
International	Company
GmbH	Company
,	O
Walldorf	O
,	O
Germany	O
-RRB-	O
.	O

Sections	O
were	O
collected	O
on	O
SuperFrost	Brandname
Plus	Brandname
slides	Brandname
-LRB-	O
Fisher	Company
Scientific	Company
-RRB-	O
and	O
dried	O
for	O
30	O
min	O
at	O
RT	O
,	O
then	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
in	O
.03	O
%	O
PBT	O
at	O
RT	O
for	O
30	O
min	O
.	O

From	O
the	O
residue	O
,	O
10	O
mg	O
were	O
used	O
for	O
NMR	O
analysis	O
-LRB-	O
1	O
H	O
and	O
13	O
C	O
NMR	O
-RRB-	O
-LRB-	O
Advance	Brandname
500	Brandname
,	O
Bruker	Company
Biospin	Company
GmbH	Company
,	O
Rheinstetten	O
,	O
Germany	O
-RRB-	O
.	O

Kinetic	O
analysis	O
of	O
α-and	O
β-ionone	O
conversion	O
For	O
the	O
estimation	O
of	O
the	O
kinetic	O
constants	O
,	O
increasing	O
concentrations	O
of	O
the	O
ionones	O
-LRB-	O
0-150	O
μM	O
-RRB-	O
with	O
fixed	O
concentrations	O
of	O
CYP109D1	O
-LRB-	O
1	O
μM	O
-RRB-	O
,	O
Adx	O
-LRB-	O
10	O
μM	O
-RRB-	O
,	O
and	O
AdR	O
-LRB-	O
1	O
μM	O
-RRB-	O
were	O
used	O
.	O

To	O
visualize	O
and	O
capture	O
the	O
tooth	O
image	O
,	O
white	O
light	O
from	O
a	O
special	O
arc	Device
lamp	Device
Philips	Company
bv	Company
,	O
Eindhoven	O
,	O
the	O
Netherlands	O
based	O
on	O
xenon	O
technology	O
was	O
filtered	O
through	O
a	O
blue-transmitting	Device
bandpass	Device
filter	Device
Philips	Company
bv	Company
with	O
a	O
peak	O
intensity	O
of	O
370	O
nm	O
and	O
a	O
bandwidth	O
of	O
80	O
nm	O
,	O
to	O
illuminate	O
the	O
tooth	O
with	O
a	O
blue-violet	O
light	O
with	O
an	O
intensity	O
of	O
13	O
mW/cm	O
2	O
.	O

Images	O
were	O
obtained	O
by	O
a	O
BZ-8000	Brandname
fluorescence	O
microscope	Device
-LRB-	O
Keyence	Company
Deutschland	Company
GmbH	Company
,	O
Germany	O
-RRB-	O
and	O
analysed	O
via	O
CellProfiler	Brandname
2.0	Brandname
r11710	Brandname
-LRB-	O
Broad	Company
Institute	Company
of	Company
MIT	Company
and	Company
Harvard	Company
,	O
USA	O
-RRB-	O
.	O


-DOCSTART- O

.	O

,	O
Canada	O
-RRB-	O
and	O
an	O
AlphaGUARD	Brandname
PQ2000Pro	Brandname
radon	Brandname
monitor	Brandname
-LRB-	O
Saphymo	Company
Gmbh	Company
,	O
Germany	O
-RRB-	O
as	O
a	O
reference	O
were	O
used	O
.	O

The	O
grab	O
sampling	O
method	O
using	O
Lucas	Device
scintillation	Device
cells	Device
-LRB-	O
1	O
dm	O
3	O
Lucas	O
covered	O
by	O
ZnS	O
-LRB-	O
Ag	O
-RRB-	O
,	O
M	Company
EV	Company
Ltd.	O
,	O
Hungary	O
-RRB-	O
and	O
an	O
EMI	Device
photomultiplier	Device
were	O
used	O
to	O
determine	O
the	O
radon	O
concentrations	O
.	O

Materials	O
and	O
methods	O
Activated	O
sludge	O
samples	O
and	O
DNA	O
extraction	O
Activated	O
sludge	O
samples	O
were	O
collected	O
from	O
one	O
industria	O
l	O
WWTP	O
-LRB-	O
plant	O
A	O
-RRB-	O
and	O
seven	O
domestic	O
WWTPs	O
-LRB-	O
plants	O
B-H	O
-RRB-	O
located	O
in	O
Japan	O
-LRB-	O
Table	O
SMTotal	O
DNA	O
of	O
each	O
activated	O
sludge	O
sample	O
was	O
extracted	O
as	O
follows	O
:	O
each	O
activated	O
sludge	O
sample	O
was	O
centrifuged	O
at	O
4000	O
g	O
for	O
15	O
min	O
and	O
the	O
total	O
DNA	O
of	O
each	O
sample	O
was	O
extracted	O
from	O
250	O
mg	O
of	O
the	O
wet	O
precipita	O
te	O
using	O
a	O
NucleoSpin	Brandname
Soil	Brandname
kit	Brandname
-LRB-	O
MACHEREY-NAG	Company
EL	Company
GmbH	Company
,	O
KG	O
,	O
Germany	O
-RRB-	O
.	O

The	O
DNA	O
extract	O
was	O
cleaned	O
up	O
using	O
a	O
NucleoSpin	Brandname
gDNA	Brandname
Clean-up	Brandname
kit	Brandname
-LRB-	O
MACHEREY-NAGEL	Company
GmbH	Company
,	O
KG	O
-RRB-	O
.	O

The	O
jugular	O
vein	O
was	O
cannulated	O
and	O
the	O
cannulae	O
were	O
subsequently	O
kept	O
patent	O
using	O
a	O
saline	O
solution	O
-LRB-	O
50	O
units	O
of	O
heparin	O
per	O
milliliter	O
saline	O
,	O
Multiparin	Brandname
,	O
CP	Company
Pharmaceuticals	Company
Ltd	Company
,	O
Wrexham	O
,	O
UK	O
+300	O
mg	O
crystapen	O
antibiotic	O
per	O
500	O
ml	O
,	O
Biochemie	Company
GmbH	Company
,	O
Tirol	O
,	O
Austria	O
-RRB-	O
.	O

.	O

,	O
Hitchin	O
,	O
Hertfordshire	O
,	O
UK	O
;	O
EGFR	O
Y845	O
and	O
c-Src	O
Y418	O
were	O
from	O
BioSource	Company
Europe	Company
S.A.	O
-LRB-	O
Fleures	O
,	O
Belgium	O
-RRB-	O
,	O
ErbB2	O
Y1248	O
was	O
from	O
Upstate	Company
Biotechnology	Company
-LRB-	O
Lake	O
Placid	O
,	O
NY	O
-RRB-	O
;	O
and	O
-	O
actin	O
was	O
from	O
Sigma-Aldrich	Company
.	O

The	O
absorbance	O
was	O
read	O
at	O
540	O
nm	O
with	O
a	O
EZ	Brandname
400	Brandname
microplate	Brandname
reader	Brandname
-LRB-	O
Biochrom	Company
Ltd	Company
,	O
Cambridge	O
,	O
UK	O
-RRB-	O
and	O
the	O
optical	O
densities	O
used	O
to	O
determine	O
cell	O
viability	O
and	O
to	O
calculate	O
IC	O
50	O
.	O

Cubes	O
of	O
cellular	O
rigid	O
polyurethane	Device
foam	Device
-LRB-	O
Sawbones	Company
Europe	Company
AB	Company
,	O
Malmö	O
,	O
Sweden	O
-RRB-	O
50	O
×	O
50	O
mm	O
with	O
three	O
different	O
qualities	O
were	O
used	O
to	O
simulate	O
``	O
severely	O
osteoporotic	O
bone	O
''	O
-LRB-	O
160	O
kg/m	O
-3	O
-RRB-	O
,	O
``	O
mildly	O
osteoporotic	O
bone	O
''	O
-LRB-	O
240	O
kg/m	O
-3	O
-RRB-	O
,	O
and	O
``	O
normal	O
bone	O
''	O
-LRB-	O
320	O
kg/m	O
-3	O
-RRB-	O
.	O

Subsequently	O
,	O
CD4	Device
‡	Device
T	Device
cells	Device
were	O
separated	O
by	O
high	O
gradient	O
magnetic	O
sorting	O
using	O
the	O
Variomacs	Brandname
technique	Brandname
-LRB-	O
Miltenyi	Company
Biotec	Company
GmbH	Company
,	O
Bergisch-Gladbach	O
,	O
Germany	O
-RRB-	O
.	O

PBMC	O
were	O
incubated	O
with	O
saturating	O
concentrations	O
of	O
CD4	O
mAb	O
conjugated	O
with	O
paramagnetic	Device
microbeads	Device
for	O
15	O
min	O
on	O
ice	O
,	O
washed	O
in	O
PBS	O
supplemented	O
with	O
0.5	O
%	O
bovine	O
serum	O
albumin	O
,	O
and	O
5	O
mM	O
EDTA	O
and	O
separated	O
according	O
to	O
the	O
manufacturer	O
's	O
instructions	O
.	O

The	O
cross-sectional	O
images	O
obtained	O
by	O
pQCT	O
were	O
analyzed	O
using	O
BonAlyse	Brandname
software	Brandname
-LRB-	O
BonAlyse	Company
Oy	Company
,	O
Jyvaskyla	O
,	O
Finland	O
-RRB-	O
,	O
which	O
automatically	O
identifies	O
cortical	O
and	O
trabecular	O
bone	O
and	O
assesses	O
its	O
density	O
.	O

AcKnOwLEdgEMEnt	O
Alexander	O
geurts	O
was	O
supported	O
by	O
an	O
unrestricted	O
grant	O
from	O
Ipsen	Company
Farmaceutica	Company
BV	Company
in	O
the	O
netherlands	O
.	O

REFEREncES	O
ELISA	O
and	O
multiplex	O
analyses	O
Serum	O
levels	O
of	O
the	O
following	O
endothelial	O
markers	O
were	O
measured	O
by	O
ELISA	Brandname
:	Brandname
sCD141	Brandname
-LRB-	O
soluble	Company
thrombomodulin	Company
,	O
Diaclone	O
,	O
Besançone	O
,	O
France	O
-RRB-	O
,	O
suppressor	O
of	O
tumorigenicity-2	O
-LRB-	O
ST2	O
-RRB-	O
,	O
interleukin-33	O
-LRB-	O
R&D	Company
Systems	Company
Europe	Company
Ltd	Company
,	O
Abingdon	O
,	O
UK	O
-RRB-	O
and	O
vascular	O
endothelial	O
growth	O
factor	O
-LRB-	O
R&D	Company
Systems	Company
-RRB-	O
.	O

Briefly	O
,	O
A172	O
and	O
T98G	O
glioblastoma	O
cells	O
and	O
primary-cultured	O
astrocytes	O
were	O
cultured	O
in	O
different	O
96-well	O
plates	O
-LRB-	O
Greiner	Company
Bio-One	O
GmbH	O
,	O
Frickenhausen	O
,	O
Germany	O
-RRB-	O
at	O
a	O
density	O
of	O
5x10	O
3	O
cells	O
/	O
well	O
.	O

After	O
identifying	O
the	O
origin	O
of	O
the	O
occluded	O
mesenteric	O
artery	O
,	O
an	O
attempt	O
was	O
made	O
to	O
cross	O
the	O
occlusion	O
from	O
below	O
,	O
using	O
a	O
Simonds	O
shape	O
catheter	O
and	O
0.035	O
guide	O
wire	O
-LRB-	O
Terumo	O
Sweden	O
AB	O
,	O
Sweden	O
-RRB-	O
.	O

If	O
this	O
failed	O
,	O
an	O
attempt	O
was	O
made	O
at	O
using	O
the	O
same	O
technique	O
from	O
the	O
arm	O
with	O
a	O
4F	Device
Headhunter	Device
catheter	Device
-LRB-	O
COOK	O
Europe	O
,	O
Bjaereskov	O
,	O
Denmark	O
-RRB-	O
and	O
0.035	O
guide	O
wire	O
.	O

DNA	O
Extraction	O
Paraffin-embedded	O
tissues	O
were	O
macrodissected	O
based	O
on	O
hematoxylin	O
and	O
eosin	O
staining	O
evaluations	O
to	O
ensure	O
a	O
minimum	O
of	O
75	O
%	O
of	O
tumor	O
cells	O
.	O

6,7	O
Corresponding	O
slides	O
were	O
digested	O
using	O
proteinase	O
K	O
-LRB-	O
Roche	Company
Diagnostics	Company
GmbH	Company
,	O
Mannheim	O
,	O
Germany	O
-RRB-	O
overnight	O
before	O
DNA	O
extraction	O
using	O
standard	O
methods	O
.	O

C-reactive	O
protein	O
was	O
measured	O
with	O
a	O
high-sensitivity	O
reagent	O
kit	O
-LRB-	O
CP	O
3847	O
,	O
Randox	Company
Laboratories	Company
Ltd	Company
,	O
Crumlin	O
,	O
United	O
Kingdom	O
-RRB-	O
.	O

Definitions	O
of	O
Outcome	O
Measures	O
Patients	O
were	O
followed	O
up	O
by	O
telephone	O
interviews	O
and	O
by	O
medical	O
records	O
at	O
1	O
year	O
.	O

Group	O
D	O
received	O
pentobarbitone	O
-LRB-	O
Nembutal	O
;	O
Abbot	Company
BV	Company
,	O
Amstelveen	O
,	O
The	O
Netherlands	O
-RRB-	O
diluted	O
to	O
15	O
mg/ml	O
injected	O
into	O
an	O
ear	O
vein	O
.	O

Color	O
Fillet	O
surface	O
color	O
-LRB-	O
CIE	O
Lab	O
-RRB-	O
was	O
assessed	O
on	O
all	O
the	O
fillets	O
in	O
the	O
design	O
-LRB-	O
n	O
=	O
80	O
-RRB-	O
by	O
a	O
digital	Device
photo	Device
imaging	Device
color-measuring	Device
system	Device
-LRB-	O
DigiEye	Brandname
full	Brandname
system	Brandname
,	O
VeriVide	Company
Ltd.	Company
,	O
Leicester	O
,	O
UK	O
-RRB-	O
after	O
7	O
d	O
of	O
storage	O
.	O

The	O
fillets	O
were	O
placed	O
in	O
a	O
standardized	O
lightbox	O
with	O
daylight	O
-LRB-	O
6400	O
K	O
-RRB-	O
and	O
photographed	O
with	O
a	O
calibrated	O
digital	Device
camera	Device
-LRB-	O
Nikon	Brandname
D80	Brandname
,	O
35	O
mm	O
lens	O
,	O
Nikon	Company
Corp.	Company
,	O
Japan	O
-RRB-	O
.	O

NE	O
tissue	O
content	O
was	O
measured	O
using	O
a	O
NE	Brandname
research	Brandname
ELISA	Brandname
kit	Brandname
-LRB-	O
Demeditec	Company
Diagnostics	Company
GmbH	Company
,	O
Kiel	O
,	O
Germany	O
-RRB-	O
,	O
fol-lowing	O
the	O
manufacturer	O
's	O
instructions	O
.	O

The	O
need	O
for	O
electrocauterization	O
-LRB-	O
Martin	Brandname
ME	Brandname
82	Brandname
,	O
KLS	Company
Martin	Company
Group	Company
,	O
Tuttlingen	O
,	O
Germany	O
-RRB-	O
and/or	O
for	O
suturing	O
-LRB-	O
Seralon	Brandname
5-0	Brandname
,	O
Serag	Company
Wiessner	Company
GmbH	Company
&	Company
Co.	Company
,	O
Naila	O
,	O
Germany	O
-RRB-	O
to	O
stop	O
the	O
bleeding	O
was	O
recorded	O
separately	O
.	O

Specific-IgE	O
Measurements	O
Serum	O
sIgE	O
levels	O
were	O
determined	O
by	O
a	O
screening	O
method	O
-LRB-	O
ImmunoCAP	O
,	O
Phadiatop	Brandname
Infant	Brandname
™	Brandname
,	O
Pharmacia	Company
Diagnostics	Company
AB	Company
,	O
Uppsala	O
,	O
Sweden	O
-RRB-	O
against	O
the	O
same	O
panel	O
of	O
inhalant	O
and	O
food	O
allergens	O
as	O
listed	O
above	O
for	O
SPT	O
.	O

Internalization	O
was	O
analyzed	O
using	O
a	O
LEICA	Brandname
TCS	Brandname
SP8	Brandname
confocal	Brandname
microscope	Brandname
and	O
the	O
corresponding	O
software	O
-LRB-	O
Leica	Company
Microsystems	Company
GmbH	Company
,	O
Wetzlar	O
,	O
Germany	O
-RRB-	O
.	O

Colorimetric	O
XTT	O
cell	O
proliferation	O
assay	O
The	O
cytotoxic	O
activity	O
of	O
425	O
-LRB-	O
scFv	O
-RRB-	O
-	O
ETA	O
′	O
against	O
three	O
different	O
RMS	O
cell	O
lines	O
-LRB-	O
RD	O
,	O
FL-OH1	O
and	O
TE-671	O
-RRB-	O
was	O
determined	O
using	O
a	O
cell	O
proliferation	O
assay	O
based	O
on	O
XTT	O
as	O
previously	O
described	O
-LRB-	O
Schiffer	O
et	O
al.	O
2013	O
-RRB-	O
.	O


-DOCSTART- O

One	O
microlitre	O
of	O
extracted	O
DNA	O
solution	O
was	O
added	O
to	O
the	O
PCR	O
mixture	O
containing	O
2.5	O
U	O
of	O
Dream	Brandname
Taq	Brandname
DNA	Brandname
polymerase	Brandname
-LRB-	O
Fermentas	Company
Life	Company
Technologies	Company
,	O
Helsingborg	O
Sweden	O
-RRB-	O
,	O
250	O
mM	O
dNTPs	O
,	O
0.8	O
mM	O
forward	O
primer	O
ITS1F	O
and	O
0.5	O
mM	O
reverse	O
primer	O
ITS4A	O
,	O
and	O
1	O
ml	O
of	O
BSA	O
-LRB-	O
Roche	Company
,	Company
Diagnostics	Company
GmbH	Company
,	O
Mannheim	O
,	O
Germany	O
-RRB-	O
in	O
25	O
ml	O
of	O
1	O
¥	O
reaction	O
buffer	O
-LRB-	O
Clontech	Company
,	O
Mountain	O
View	O
,	O
USA	O
-RRB-	O
.	O

Serum	O
25	O
-LRB-	O
OH	O
-RRB-	O
D	O
3	O
and	O
parathyroid	O
hormone	O
-LRB-	O
PTH	O
-RRB-	O
were	O
analysed	O
using	O
chemoluminescence	O
on	O
a	O
Cobas	Brandname
e602	Brandname
unit	Brandname
-LRB-	O
Roche	Company
Diagnostics	Company
Scandinavia	Company
AB	Company
,	O
Bromma	O
,	O
Sweden	O
-RRB-	O
.	O

Calcium	O
levels	O
were	O
measured	O
on	O
a	O
KonelabTM	Brandname
PRIME	Brandname
30i	Brandname
equipment	O
-LRB-	O
Thermo	Company
Fischer	Company
Scientific	Company
Inc	Company
,	O
Waltham	O
,	O
MA	O
,	O
USA	O
-RRB-	O
.	O

G	O
-LRB-	O
Zimmer	Company
Surgical	Company
,	O
Dover	O
,	O
OH	O
,	O
USA	O
-RRB-	O
;	O
Refobacin	O
Ò	O
Bone	O
Cement	O
R40	O
-LRB-	O
Biomet	Company
-RRB-	O
;	O
Simplex	O
TM	O
P	O
with	O
Tobramycin	O
-LRB-	O
Stryker	Company
Orthopaedics	Company
,	O
Limerick	O
,	O
Ireland	O
-RRB-	O
;	O
SmartSet	Brandname
GHV	Brandname
Gentamicin	O
-LRB-	O
DePuy	Company
Ltd.	Company
,	O
Blackpool	O
,	O
UK	O
-RRB-	O
;	O
and	O
SmartSet	Brandname
GMV	Brandname
Gentamicin	O
-LRB-	O
DePuy	Company
Ltd.	Company
-RRB-	O
.	O

Peritoneal	O
Macrophages-Peritoneal	O
macrophages	O
from	O
C3H/HeN	Brandname
and	O
C3H/HeJ	Brandname
mice	Device
-LRB-	O
Harlan	Company
Ltd.	Company
,	O
Oxon	O
,	O
UK	O
-RRB-	O
were	O
collected	O
by	O
lavage	O
4	O
days	O
after	O
intraperitoneal	O
injections	O
of	O
3	O
ml	O
of	O
3	O
%	O
thioglycollate	O
-LRB-	O
Difco	Company
,	O
Detroit	O
,	O
MI	O
-RRB-	O
.	O

The	O
England	O
Finders	O
were	O
positioned	O
in	O
Quadriperm	Brandname
culture	Device
flasks	Device
-LRB-	O
Greiner	Company
Bio-One	Company
GmbH	Company
,	O
Frickenhausen	O
,	O
Germany	O
-RRB-	O
in	O
which	O
cells	O
were	O
incubated	O
with	O
6	O
ml	O
of	O
Dulbecco	O
's	O
modified	O
Eagle	O
's	O
medium	O
-LRB-	O
DMEM	Brandname
cell	Brandname
culture	Brandname
;	O
Gibco-Invitrogen	Company
,	O
Paisley	O
,	O
UK	O
-RRB-	O
supplemented	O
with	O
10	O
%	O
fetal	O
calf	O
serum	O
,	O
100	O
U/ml	O
penicillin	O
,	O
100	O
mg/ml	O
streptomycin	O
,	O
and	O
2	O
mMol/ml	O
glutamine	O
-LRB-	O
all	O
from	O
Biochrom	Company
,	O
Berlin	O
,	O
Germany	O
-RRB-	O
at	O
37	O
C	O
in	O
a	O
humidified	O
atmosphere	O
of	O
5	O
%	O
CO	O
2	O
.	O

All	O
of	O
the	O
cements	O
were	O
tested	O
in	O
their	O
proprietary	O
forms	O
with	O
pre-mixed	O
gentamicin	O
and	O
also	O
with	O
the	O
addition	O
of	O
1	O
g	O
vancomycin	O
and	O
2	O
g	O
vancomycin	O
.	O

The	O
vancomycin	O
-LRB-	O
Alpharma	Company
Ltd	Company
,	O
Barnstaple	O
,	O
United	O
Kingdom	O
-RRB-	O
was	O
mixed	O
into	O
the	O
cement	O
polymer	O
as	O
a	O
powder	O
,	O
manually	O
using	O
a	O
metal	Device
spatula	Device
as	O
done	O
in	O
clinical	O
practice	O
,	O
prior	O
to	O
adding	O
the	O
monomer	O
.	O

The	O
PCR	O
products	O
were	O
analyzed	O
by	O
electrophoresis	O
in	O
a	O
1	O
%	O
low-melting-temperature	O
agarose	O
gel	O
and	O
subsequently	O
purified	O
by	O
using	O
a	O
QIAquick	Brandname
gel	Device
extraction	Device
kit	Device
-LRB-	O
Qiagen	Company
Ltd.	Company
,	O
Crawley	O
,	O
United	O
Kingdom	O
-RRB-	O
.	O

Purified	O
amplicons	O
were	O
sequenced	O
by	O
using	O
an	O
ABI	Brandname
PRISM	Brandname
BigDye	Brandname
terminator	Brandname
cycle	O
sequencing	O
ready	O
reaction	Device
kit	Device
-LRB-	O
version	O
3.0	O
-RRB-	O
and	O
an	O
ABI	Brandname
PRISM	Brandname
3100	Brandname
genetic	Device
analyzer	Device
-LRB-	O
Applied	Company
Biosystems	Company
-RRB-	O
according	O
to	O
the	O
manufacturer	O
's	O
instructions	O
.	O

Samples	O
were	O
analysed	O
using	O
a	O
PDZ	Brandname
Europa	Brandname
ANCA-GSL	Brandname
elemental	Device
analyzer	Device
interfaced	O
to	O
a	O
PDZ	Brandname
Europa	Brandname
20-20	Brandname
isotope	Device
ratio	Device
mass	Device
spectrometer	Device
-LRB-	O
Sercon	Company
Ltd.	Company
,	O
Cheshire	O
,	O
UK	O
-RRB-	O
.	O

The	O
samples	O
were	O
reacted	O
with	O
chromium	O
oxide	O
and	O
silvered	O
copper	O
oxide	O
at	O
1000	O
°C	O
,	O
the	O
oxides	O
were	O
removed	O
,	O
and	O
N	O
2	O
and	O
CO	O
2	O
were	O
trapped	O
and	O
separated	O
on	O
a	O
Carosieve	O
GC	O
column	O
before	O
the	O
IRMS	O
.	O

Mycobacteria	O
were	O
identified	O
by	O
16S	O
rRNA	O
gene	O
sequence	O
analysis	O
,	O
as	O
previously	O
described	O
-LRB-	O
18	O
-RRB-	O
and	O
analyzed	O
using	O
SmartGene	Brandname
IDNS	Brandname
software	Device
-LRB-	O
SmartGene	Company
GmbH	Company
,	O
Zug	O
,	O
Switzerland	O
-RRB-	O
.	O

Genotypic	O
resistance	O
testing	O
.	O

Mycobacterium	O
tuberculosis	O
clinical	O
isolates	O
were	O
analyzed	O
for	O
antibiotic	O
resistance	O
mutations	O
by	O
DNA	O
sequencing	O
.	O

HR	O
was	O
recorded	O
continuously	O
during	O
the	O
test	O
by	O
Team2	Brandname
Pro	Brandname
-LRB-	O
Polar	Company
Electro	Company
Oy	Company
,	O
Kempele	O
,	O
Finland	O
-RRB-	O
.	O

Statistical	O
analyses	O
Statistical	O
analyses	O
were	O
performed	O
using	O
IBM	Brandname
SPSS	Brandname
v.	O
20.0	O
-LRB-	O
SPSS	Company
,	O
Chicago	O
,	O
USA	O
-RRB-	O
.	O

Labelling	O
efficiency	O
was	O
measured	O
using	O
instant	O
thin	O
layer	O
chromatography	O
strips	O
-LRB-	O
ITLC-SA	Brandname
-RRB-	O
-LRB-	O
Varian	Company
Medical	Company
Systems	Company
UK	Company
,	O
Ltd.	O
,	O
Crawley	O
,	O
UK	O
-RRB-	O
with	O
a	O
mobile	O
phase	O
of	O
0.1	O
M	O
citrate	O
buffer	O
,	O
pH	O
5	O
and	O
analysed	O
using	O
a	O
gamma	Device
ray	Device
TLC	Device
scanner	Device
-LRB-	O
Lablogic	Company
,	O
UK	O
-RRB-	O
.	O

Microdialysis	Device
pumps	Device
-LRB-	O
CMA	Brandname
106	Brandname
;	O
CMA	Company
Microdialysis	Company
AB	Company
,	O
Solna	O
,	O
Sweden	O
-RRB-	O
were	O
used	O
at	O
a	O
constant	O
flow	O
rate	O
of	O
0.3	O
ml/min	O
.	O

The	O
inlet	O
tube	O
was	O
connected	O
to	O
a	O
zero-air	Device
generator	Device
-LRB-	O
Peak	Company
Scientific	Company
-RRB-	O
and	O
the	O
outlet	O
to	O
the	O
PTR-ToFMS	Brandname
-LRB-	O
8000	O
,	O
Ionicon	Company
Analitic	Company
GmbH	Company
,	O
Innsbruck	O
,	O
Austria	O
-RRB-	O
.	O

Care	O
was	O
taken	O
to	O
maintain	O
constant	O
temperature	O
and	O
humidity	O
during	O
measurements	O
as	O
chemical	O
reactions	O
are	O
very	O
sensitive	O
to	O
changes	O
of	O
such	O
parameters	O
-LRB-	O
Mancuso	O
et	O
al.	O
,	O
2015	O
-RRB-	O
.	O

The	O
plasma	O
FFA	O
concentration	O
was	O
measured	O
spectrophotometrically	O
-LRB-	O
Wako	Company
Chemicals	Company
Gmbh	Company
,	O
Neuss	O
,	O
Germany	O
-RRB-	O
.	O

The	O
3	O
-	O
-LSB-	O
3	O
H	O
-RSB-	O
glucose-specific	O
activity	O
was	O
measured	O
on	O
barium	O
hydroxide/zinc	O
sulfate-deproteinized	O
plasma	O
samples	O
.	O

NOV.	O
137	O
algorithm	O
was	O
implemented	O
as	O
part	O
of	O
the	O
program	Device
package	Device
SAGE	Brandname
-LRB-	O
Technoma	Company
GmbH	Company
,	O
Heidelberg	O
,	O
Germany	O
-RRB-	O
.	O

Chemotaxonomic	O
analysis	O
.	O

Quinones	O
were	O
extracted	O
and	O
analyzed	O
as	O
described	O
by	O
Auling	O
et	O
al.	O
-LRB-	O
3	O
-RRB-	O
.	O

Superfect	O
reagent	O
for	O
transfection	O
was	O
purchased	O
from	O
Qiagen	O
-LRB-	O
Qiagen	Company
GmbH	Company
,	O
Germany	O
-RRB-	O
.	O

iNOS	O
,	O
COX-2	O
,	O
TNF-α	O
,	O
IL-6	O
,	O
and	O
β-actin	Brandname
oligonucleotide	Brandname
primers	O
were	O
purchased	O
from	O
Bioneer	Company
-LRB-	O
Seoul	O
,	O
South	O
Korea	O
-RRB-	O
.	O

3	O
-	O
-LRB-	O
4,5-dimethylthiazol-2-yl	O
-RRB-	O
-2,5-Diphenyl-tetrazolium	O
bromide	O
-LRB-	O
MTT	O
-RRB-	O
,	O
aprotinin	O
,	O
leupeptin	O
,	O
phenylmethyl	O
sulfonylfluoride	O
-LRB-	O
PMSF	O
-RRB-	O
,	O
dithiothreitol	O
,	O
L-N6	O
-	O
-LRB-	O
1-iminoethyl	O
-RRB-	O
lysine	O
-LRB-	O
L-NIL	O
-RRB-	O
,	O
Triton	Brandname
X100	Brandname
,	O
Escherichia	O
coli	O
LPS	O
,	O
and	O
all	O
other	O
chemicals	O
were	O
purchased	O
from	O
Sigma	Company
Chemical	Company
Co.	Company
.	Company

Particle	O
size	O
measurement	O
and	O
emulsifying	O
activity	O
EPS	O
-LRB-	O
50	O
%	O
w/v	O
-RRB-	O
samples	O
dissolved	O
in	O
water	O
were	O
sonicated	O
for	O
5	O
min	O
,	O
and	O
the	O
particle	O
size	O
distributions	O
were	O
measured	O
by	O
laser	O
diffraction	O
-LRB-	O
Malvern	Brandname
Mastersizer	Brandname
2000	Brandname
,	O
Malvern	Company
Ltd	Company
,	O
Worcestershire	O
,	O
UK	O
-RRB-	O
.	O

Lyophilised	O
EPS	O
-LRB-	O
1	O
mg	O
-RRB-	O
was	O
dissolved	O
in	O
0.5	O
ml	O
deionised	O
water	O
,	O
heated	O
to	O
1008C	O
for	O
15	O
min	O
and	O
allowed	O
to	O
cool	O
to	O
room	O
temperature	O
-LRB-	O
25	O
+	O
28C	O
-RRB-	O
.	O

In	O
the	O
present	O
study	O
,	O
twelve	O
short-glassfibre-reinforced	O
-LRB-	O
SGFR	O
-RRB-	O
third-generation	O
composite	O
replicate	Device
femurs	Device
-LRB-	O
Sawbones	Company
Europe	Company
AB	Company
,	O
Malmö	O
,	O
Sweden	O
-RRB-	O
were	O
used	O
in	O
two	O
configurations	O
:	O
-LRB-	O
1	O
-RRB-	O
MDF	O
SP	O
:	O
singleplane	O
oblique	O
medial	O
closing-wedge	O
SCO	Device
fixated	O
with	O
a	O
medial	O
angle	O
stable	O
implant	O
-LRB-	O
Tomofix	Company
,	O
Synthes	O
,	O
Bettlach	O
,	O
Swiss	O
-RRB-	O
and	O
-LRB-	O
2	O
-RRB-	O
MDF	O
BP	O
:	O
bi-plane	O
oblique	O
medial	O
closingwedge	O
SCO	O
-LRB-	O
Fig.	O
1	O
-RRB-	O
.	O

The	O
10	O
lL	O
reaction	O
mixture	O
prepared	O
in	O
a	O
LightCycler	Brandname
Ò	Brandname
480	Brandname
Multiwell	Device
Plate	Device
96	O
contained	O
LightCycler	Brandname
Ò	Brandname
480	Brandname
Probes	Brandname
Master	Brandname
reaction	Device
mixture	Device
-LRB-	O
Roche	Company
Diagnostics	Company
,	Company
GmbH	Company
,	O
Mannheim	O
,	O
Germany	O
-RRB-	O
,	O
2.5	O
pmol	O
of	O
each	O
primer	O
,	O
1	O
pmol	O
of	O
UPL	O
probe	O
,	O
4	O
mM	O
MgCl	O
2	O
,	O
and	O
1	O
lL	O
cDNA	O
.	O

PGI32	O
modElInG	O
thE	O
Cost-EffECtIvEnEss	O
of	O
thE	O
all	O
oRal	O
,	O
dIRECt-aCtInG	O
antIvIRal	O
REGImEn	O
daClatasvIR	O
Plus	O
sofosBuvIR	O
In	O
PatIEnts	O
Co-InfECtEd	O
WIth	O
hEPatItIs	O
C	O
vIRus	O
-LRB-	O
hCv	O
-RRB-	O
and	O
hIv	O
McEwan	O
P	O
1	O
,	O
Ward	O
T	O
1	O
,	O
Webster	O
S	O
1	O
,	O
Kalsekar	O
A	O
2	O
,	O
Brenner	O
M	O
3	O
,	O
Yuan	O
Y	O
2	O
1	O
Health	Company
Economics	Company
and	Company
Outcomes	Company
Research	Company
Ltd	Company
,	O
Monmouth	O
,	O
UK	O
,	O
2	O
Bristol-Myers	Company
Squibb	Company
Pharmaceuticals	Company
Ltd	Company
,	O
Princeton	O
,	O
NJ	O
,	O
USA	O
,	O
3	O
Bristol-Myers	Company
Squibb	Company
Pharmaceuticals	Company
Ltd	Company
,	O
Uxbridge	O
,	O
UK	O
objeCtives	O
:	O
Compared	O
to	O
infection	O
with	O
hepatitis	O
C	O
virus	O
-LRB-	O
HCV	O
-RRB-	O
alone	O
,	O
patients	O
co-infected	O
with	O
HIV	O
have	O
faster	O
disease	O
progression	O
,	O
decreased	O
quality	O
of	O
life	O
and	O
increased	O
rates	O
of	O
mortality	O
.	O


